(266809, 'HP:0000958', 'Dry skin', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(266810, 'HP:0000958', 'Dry skin', 'MP:0009603', 'absent keratohyalin granules', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(266811, 'HP:0000958', 'Dry skin', 'MP:0001204', 'decreased sensitivity to skin irradiation', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(266812, 'HP:0000958', 'Dry skin', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(266813, 'HP:0000958', 'Dry skin', 'MP:0010206', 'pigment incontinence', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(266814, 'HP:0000958', 'Dry skin', 'MP:0010071', 'abnormal pruritus', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(266815, 'HP:0000958', 'Dry skin', 'MP:0010232', 'delayed skin pigmentation appearance', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(266816, 'HP:0000958', 'Dry skin', 'MP:0014136', 'abnormal extraembryonic endoderm morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(266817, 'HP:0000958', 'Dry skin', 'MP:0001510', 'abnormal coat appearance', 0.41379310344827586, 6.904974582545727, 1.6903345413683823, 'UPHENO:0003811', 'abnormal skin of body'),
(266818, 'HP:0000958', 'Dry skin', 'MP:0009604', 'increased keratohyalin granule number', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(266819, 'HP:0000958', 'Dry skin', 'MP:0009932', 'skin fibrosis', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(266820, 'HP:0000958', 'Dry skin', 'MP:0001211', 'wrinkled skin', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(266821, 'HP:0000958', 'Dry skin', 'MP:0001189', 'absent skin pigmentation', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(266822, 'HP:0000958', 'Dry skin', 'MP:0006281', 'abnormal tail development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(266823, 'HP:0000958', 'Dry skin', 'MP:0002015', 'epithelioid cyst', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(266824, 'HP:0000958', 'Dry skin', 'MP:0010700', 'hair follicle comedo', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(266825, 'HP:0000958', 'Dry skin', 'MP:0014134', 'abnormal embryo morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(266826, 'HP:0000958', 'Dry skin', 'MP:0001201', 'translucent skin', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(266827, 'HP:0000958', 'Dry skin', 'MP:0000003', 'abnormal adipose tissue morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(266828, 'HP:0000958', 'Dry skin', 'MP:0001212', 'skin lesions', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(266829, 'HP:0000958', 'Dry skin', 'MP:0001209', 'spontaneous skin ulceration', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(266830, 'HP:0000958', 'Dry skin', 'MP:0000574', 'abnormal foot pad morphology', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(266831, 'HP:0000958', 'Dry skin', 'MP:0001198', 'tight skin', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(266832, 'HP:0000958', 'Dry skin', 'MP:0011239', 'abnormal skin coloration', 0.5416666666666666, 7.4735768925632104, 2.012010806002726, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(266833, 'HP:0000958', 'Dry skin', 'MP:0008856', 'fetal bleb', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(266834, 'HP:0000958', 'Dry skin', 'MP:0011515', 'purpura', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(266835, 'HP:0000958', 'Dry skin', 'MP:0009385', 'abnormal dermal pigmentation', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(266836, 'HP:0000958', 'Dry skin', 'MP:0002095', 'abnormal skin pigmentation', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(266837, 'HP:0000958', 'Dry skin', 'MP:0009607', 'decreased keratohyalin granule size', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(266838, 'HP:0000958', 'Dry skin', 'MP:0005275', 'abnormal skin tensile strength', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(266839, 'HP:0000958', 'Dry skin', 'MP:0001195', 'flaky skin', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(266840, 'HP:0000958', 'Dry skin', 'MP:0011160', 'dermal-epidermal separation', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(266841, 'HP:0000958', 'Dry skin', 'MP:0000462', 'abnormal digestive system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(266842, 'HP:0000958', 'Dry skin', 'MP:0003279', 'aneurysm', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(266843, 'HP:0000958', 'Dry skin', 'MP:0008438', 'abnormal cutaneous collagen fibril morphology', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(266844, 'HP:0000958', 'Dry skin', 'MP:0009473', 'abnormal skin exfoliation', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(266845, 'HP:0000958', 'Dry skin', 'MP:0008816', 'petechiae', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(266846, 'HP:0000958', 'Dry skin', 'MP:0014137', 'abnormal preimplantation embryo morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(266847, 'HP:0000958', 'Dry skin', 'MP:0009605', 'decreased keratohyalin granule number', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(266848, 'HP:0000958', 'Dry skin', 'MP:0001192', 'scaly skin', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(266849, 'HP:0000958', 'Dry skin', 'MP:0013488', 'increased keratoacanthoma incidence', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(266850, 'HP:0000958', 'Dry skin', 'MP:0031103', 'skin rash', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(266851, 'HP:0000958', 'Dry skin', 'MP:0031310', 'abnormal cyst', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(266852, 'HP:0000958', 'Dry skin', 'MP:0030923', 'abnormal hair follicle ostium morphology', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(266853, 'HP:0000958', 'Dry skin', 'MP:0001236', 'abnormal epidermis stratum spinosum morphology', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(266854, 'HP:0000958', 'Dry skin', 'MP:0009606', 'increased keratohyalin granule size', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(266855, 'HP:0000958', 'Dry skin', 'MP:0004241', 'acantholysis', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(266856, 'HP:0000958', 'Dry skin', 'MP:0002060', 'abnormal skin morphology', 0.5652173913043478, 7.4735768925632104, 2.055284806280393, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(266857, 'HP:0000958', 'Dry skin', 'MP:0002897', 'blotchy skin', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(266858, 'HP:0000958', 'Dry skin', 'MP:0001202', 'skin photosensitivity', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(266859, 'HP:0000958', 'Dry skin', 'MP:0001243', 'abnormal dermal layer morphology', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(266860, 'HP:0000958', 'Dry skin', 'MP:0000685', 'abnormal immune system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(266861, 'HP:0000958', 'Dry skin', 'MP:0009931', 'abnormal skin appearance', 0.5416666666666666, 7.4735768925632104, 2.012010806002726, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(266862, 'HP:0000958', 'Dry skin', 'MP:0010016', 'variable depigmentation', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(266863, 'HP:0000958', 'Dry skin', 'MP:0009387', 'abnormal epidermal pigmentation', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(266864, 'HP:0011147', 'Typical absence seizure', 'MP:0002193', 'minimal clonic seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266865, 'HP:0011147', 'Typical absence seizure', 'MP:0003444', 'abnormal neurotransmitter uptake', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266866, 'HP:0011147', 'Typical absence seizure', 'MP:0012348', 'decreased susceptibility to induction of seizure by inducing agent', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266867, 'HP:0011147', 'Typical absence seizure', 'MP:0003467', 'abnormal single cell response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266868, 'HP:0011147', 'Typical absence seizure', 'MP:0002915', 'abnormal synaptic depression', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266869, 'HP:0011147', 'Typical absence seizure', 'MP:0001790', 'abnormal immune system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(266870, 'HP:0011147', 'Typical absence seizure', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266871, 'HP:0011147', 'Typical absence seizure', 'MP:0000920', 'abnormal myelination', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266872, 'HP:0011147', 'Typical absence seizure', 'MP:0006277', 'abnormal parasympathetic nervous system physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266873, 'HP:0011147', 'Typical absence seizure', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266874, 'HP:0011147', 'Typical absence seizure', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(266875, 'HP:0011147', 'Typical absence seizure', 'MP:0004494', 'abnormal synaptic glutamate release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266876, 'HP:0011147', 'Typical absence seizure', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266877, 'HP:0011147', 'Typical absence seizure', 'MP:0014254', 'increased paired-pulse ratio', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266878, 'HP:0011147', 'Typical absence seizure', 'MP:0008921', 'increased neurotransmitter release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266879, 'HP:0011147', 'Typical absence seizure', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266880, 'HP:0011147', 'Typical absence seizure', 'MP:0021001', 'impaired neuron physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266881, 'HP:0011147', 'Typical absence seizure', 'MP:0002064', 'seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266882, 'HP:0011147', 'Typical absence seizure', 'MP:0001500', 'decreased kindling response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266883, 'HP:0011147', 'Typical absence seizure', 'MP:0003476', 'decreased summary potential intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266884, 'HP:0011147', 'Typical absence seizure', 'MP:0002826', 'tonic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266885, 'HP:0011147', 'Typical absence seizure', 'MP:0002635', 'reduced sensorimotor gating', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266886, 'HP:0011147', 'Typical absence seizure', 'MP:0000951', 'sporadic seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266887, 'HP:0011147', 'Typical absence seizure', 'MP:0001912', 'increased cerebrospinal fluid production', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266888, 'HP:0011147', 'Typical absence seizure', 'MP:0001900', 'impaired synaptic plasticity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266889, 'HP:0011147', 'Typical absence seizure', 'MP:0014256', 'decreased paired-pulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266890, 'HP:0011147', 'Typical absence seizure', 'MP:0002194', 'maximal tonic hindlimb extension seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266891, 'HP:0011147', 'Typical absence seizure', 'MP:0005621', 'abnormal cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(266892, 'HP:0011147', 'Typical absence seizure', 'MP:0003470', 'abnormal summary potential', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266893, 'HP:0011147', 'Typical absence seizure', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266894, 'HP:0011147', 'Typical absence seizure', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(266895, 'HP:0011147', 'Typical absence seizure', 'MP:0003219', 'increased spike-wave discharge type II', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266896, 'HP:0011147', 'Typical absence seizure', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266897, 'HP:0011147', 'Typical absence seizure', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(266898, 'HP:0011147', 'Typical absence seizure', 'MP:0003473', 'decreased summary potential threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266899, 'HP:0011147', 'Typical absence seizure', 'MP:0002921', 'abnormal post-tetanic potentiation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266900, 'HP:0011147', 'Typical absence seizure', 'MP:0020371', 'abnormal glymphatic system physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266901, 'HP:0011147', 'Typical absence seizure', 'MP:0021009', 'abnormal synaptic physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266902, 'HP:0011147', 'Typical absence seizure', 'MP:0009435', 'abnormal miniature inhibitory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266903, 'HP:0011147', 'Typical absence seizure', 'MP:0006058', 'decreased cerebral infarct size', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266904, 'HP:0011147', 'Typical absence seizure', 'MP:0003468', 'increased single cell response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266905, 'HP:0011147', 'Typical absence seizure', 'MP:0005645', 'abnormal hypothalamus physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266906, 'HP:0011147', 'Typical absence seizure', 'MP:0004836', 'abnormal synaptic acetylcholine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266907, 'HP:0011147', 'Typical absence seizure', 'MP:0005666', 'abnormal adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(266908, 'HP:0011147', 'Typical absence seizure', 'MP:0009244', 'abnormal acid-activated cation-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266909, 'HP:0011147', 'Typical absence seizure', 'MP:0002634', 'abnormal sensorimotor gating', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266910, 'HP:0011147', 'Typical absence seizure', 'MP:0002911', 'abnormal inhibitory postsynaptic potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266911, 'HP:0011147', 'Typical absence seizure', 'MP:0005402', 'abnormal action potential', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266912, 'HP:0011147', 'Typical absence seizure', 'MP:0006060', 'increased cerebral infarct size', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266913, 'HP:0011147', 'Typical absence seizure', 'MP:0003880', 'abnormal central pattern generator function', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266914, 'HP:0011147', 'Typical absence seizure', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266915, 'HP:0011147', 'Typical absence seizure', 'MP:0001533', 'abnormal skeleton physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(266916, 'HP:0011147', 'Typical absence seizure', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266917, 'HP:0011147', 'Typical absence seizure', 'MP:0003474', 'abnormal summary potential intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266918, 'HP:0011147', 'Typical absence seizure', 'MP:0030990', 'nerve inflammation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266919, 'HP:0011147', 'Typical absence seizure', 'MP:0021015', 'increased tau protein phosphorylation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266920, 'HP:0011147', 'Typical absence seizure', 'MP:0002945', 'abnormal inhibitory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266921, 'HP:0011147', 'Typical absence seizure', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266922, 'HP:0011147', 'Typical absence seizure', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266923, 'HP:0011147', 'Typical absence seizure', 'MP:0002918', 'abnormal paired-pulse facilitation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266924, 'HP:0011147', 'Typical absence seizure', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(266925, 'HP:0011147', 'Typical absence seizure', 'MP:0014255', 'increased paired-pulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266926, 'HP:0011147', 'Typical absence seizure', 'MP:0001986', 'abnormal taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(266927, 'HP:0011147', 'Typical absence seizure', 'MP:0002204', 'abnormal synaptic neurotransmitter level', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266928, 'HP:0011147', 'Typical absence seizure', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266929, 'HP:0011147', 'Typical absence seizure', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266930, 'HP:0011147', 'Typical absence seizure', 'MP:0010149', 'abnormal synaptic dopamine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266931, 'HP:0011147', 'Typical absence seizure', 'MP:0002919', 'enhanced paired-pulse facilitation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266932, 'HP:0011147', 'Typical absence seizure', 'MP:0005446', 'abnormal synaptic epinephrine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266933, 'HP:0011147', 'Typical absence seizure', 'MP:0004008', 'abnormal GABA-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266934, 'HP:0011147', 'Typical absence seizure', 'MP:0003465', 'increased single cell response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266935, 'HP:0011147', 'Typical absence seizure', 'MP:0003469', 'decreased single cell response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266936, 'HP:0011147', 'Typical absence seizure', 'MP:0009475', 'abnormal nicotine-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266937, 'HP:0011147', 'Typical absence seizure', 'MP:0012006', 'abnormal hippocampus physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266938, 'HP:0011147', 'Typical absence seizure', 'MP:0002207', 'abnormal long-term potentiation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266939, 'HP:0011147', 'Typical absence seizure', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266940, 'HP:0011147', 'Typical absence seizure', 'MP:0003220', 'decreased spike-wave discharge type II', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266941, 'HP:0011147', 'Typical absence seizure', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266942, 'HP:0011147', 'Typical absence seizure', 'MP:0012011', 'febrile seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266943, 'HP:0011147', 'Typical absence seizure', 'MP:0021016', 'decreased tau protein phosphorylation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266944, 'HP:0011147', 'Typical absence seizure', 'MP:0000947', 'convulsive seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266945, 'HP:0011147', 'Typical absence seizure', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266946, 'HP:0011147', 'Typical absence seizure', 'MP:0013806', 'encephalopathy', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266947, 'HP:0011147', 'Typical absence seizure', 'MP:0003990', 'decreased neurotransmitter release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266948, 'HP:0011147', 'Typical absence seizure', 'MP:0000427', 'abnormal hair cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(266949, 'HP:0011147', 'Typical absence seizure', 'MP:0002920', 'decreased paired-pulse facilitation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266950, 'HP:0011147', 'Typical absence seizure', 'MP:0004183', 'abnormal sympathetic nervous system physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266951, 'HP:0011147', 'Typical absence seizure', 'MP:0003471', 'abnormal summary potential threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266952, 'HP:0011147', 'Typical absence seizure', 'MP:0003483', 'decreased nerve fiber response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266953, 'HP:0011147', 'Typical absence seizure', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266954, 'HP:0011147', 'Typical absence seizure', 'MP:0003218', 'decreased spike-wave discharge type I', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266955, 'HP:0011147', 'Typical absence seizure', 'MP:0014252', 'abnormal paired-pulse ratio', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266956, 'HP:0011147', 'Typical absence seizure', 'MP:0001919', 'abnormal reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(266957, 'HP:0011147', 'Typical absence seizure', 'MP:0003475', 'increased summary potential intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266958, 'HP:0011147', 'Typical absence seizure', 'MP:0003412', 'abnormal afterhyperpolarization', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266959, 'HP:0011147', 'Typical absence seizure', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(266960, 'HP:0011147', 'Typical absence seizure', 'MP:0020424', 'increased kindling response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266961, 'HP:0011147', 'Typical absence seizure', 'MP:0004811', 'abnormal neuron physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266962, 'HP:0011147', 'Typical absence seizure', 'MP:0003466', 'decreased single cell response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266963, 'HP:0011147', 'Typical absence seizure', 'MP:0001650', 'abnormal seizure response to electrical stimulation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266964, 'HP:0011147', 'Typical absence seizure', 'MP:0000948', 'nonconvulsive seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266965, 'HP:0011147', 'Typical absence seizure', 'MP:0002195', 'psychomotor seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266966, 'HP:0011147', 'Typical absence seizure', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266967, 'HP:0011147', 'Typical absence seizure', 'MP:0003486', 'abnormal channel response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266968, 'HP:0011147', 'Typical absence seizure', 'MP:0002578', 'impaired ability to fire action potentials', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266969, 'HP:0011147', 'Typical absence seizure', 'MP:0008814', 'decreased nerve conduction velocity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266970, 'HP:0011147', 'Typical absence seizure', 'MP:0002206', 'abnormal CNS synaptic transmission', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266971, 'HP:0011147', 'Typical absence seizure', 'MP:0003635', 'abnormal synaptic transmission', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266972, 'HP:0011147', 'Typical absence seizure', 'MP:0004859', 'abnormal synaptic plasticity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266973, 'HP:0011147', 'Typical absence seizure', 'MP:0008840', 'abnormal spike wave discharge', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266974, 'HP:0011147', 'Typical absence seizure', 'MP:0011399', 'increased endoneurial fluid pressure', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266975, 'HP:0011147', 'Typical absence seizure', 'MP:0001499', 'abnormal kindling response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266976, 'HP:0011147', 'Typical absence seizure', 'MP:0003464', 'abnormal single cell response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266977, 'HP:0011147', 'Typical absence seizure', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(266978, 'HP:0011147', 'Typical absence seizure', 'MP:0004770', 'abnormal synaptic vesicle recycling', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266979, 'HP:0011147', 'Typical absence seizure', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266980, 'HP:0011147', 'Typical absence seizure', 'MP:0014253', 'decreased paired-pulse ratio', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266981, 'HP:0011147', 'Typical absence seizure', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266982, 'HP:0011147', 'Typical absence seizure', 'MP:0003484', 'abnormal channel response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266983, 'HP:0011147', 'Typical absence seizure', 'MP:0002912', 'abnormal excitatory postsynaptic potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266984, 'HP:0011147', 'Typical absence seizure', 'MP:0000950', 'abnormal seizure response to pharmacological agent', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266985, 'HP:0011147', 'Typical absence seizure', 'MP:0001752', 'abnormal hypothalamus secretion', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266986, 'HP:0011147', 'Typical absence seizure', 'MP:0006080', 'brain ischemia', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266987, 'HP:0011147', 'Typical absence seizure', 'MP:0002914', 'abnormal endplate potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266988, 'HP:0011147', 'Typical absence seizure', 'MP:0003217', 'increased spike-wave discharge type I', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266989, 'HP:0011147', 'Typical absence seizure', 'MP:0004994', 'abnormal brain wave pattern', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266990, 'HP:0011147', 'Typical absence seizure', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266991, 'HP:0011147', 'Typical absence seizure', 'MP:0012685', 'abnormal primitive streak elongation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(266992, 'HP:0011147', 'Typical absence seizure', 'MP:0004768', 'abnormal axonal transport', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266993, 'HP:0011147', 'Typical absence seizure', 'MP:0002106', 'abnormal muscle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(266994, 'HP:0011147', 'Typical absence seizure', 'MP:0004558', 'delayed allantois development', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(266995, 'HP:0011147', 'Typical absence seizure', 'MP:0003633', 'abnormal nervous system physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266996, 'HP:0011147', 'Typical absence seizure', 'MP:0013438', 'dysmyelination', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266997, 'HP:0011147', 'Typical absence seizure', 'MP:0001663', 'abnormal digestive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(266998, 'HP:0011147', 'Typical absence seizure', 'MP:0004807', 'abnormal paired-pulse inhibition', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(266999, 'HP:0011147', 'Typical absence seizure', 'MP:0003076', 'increased susceptibility to ischemic brain injury', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(267000, 'HP:0011147', 'Typical absence seizure', 'MP:0001496', 'audiogenic seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(267001, 'HP:0011147', 'Typical absence seizure', 'MP:0003463', 'abnormal single cell response', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(267002, 'HP:0011147', 'Typical absence seizure', 'MP:0002886', 'abnormal glutamate-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(267003, 'HP:0011147', 'Typical absence seizure', 'MP:0010050', 'hypermyelination', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(267004, 'HP:0011147', 'Typical absence seizure', 'MP:0004753', 'abnormal miniature excitatory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(267005, 'HP:0011147', 'Typical absence seizure', 'MP:0003997', 'tonic-clonic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(267006, 'HP:0011147', 'Typical absence seizure', 'MP:0011987', 'abnormal GABAergic neuron physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(267007, 'HP:0011147', 'Typical absence seizure', 'MP:0003477', 'abnormal nerve fiber response', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(267008, 'HP:0011147', 'Typical absence seizure', 'MP:0001983', 'abnormal olfactory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267009, 'HP:0011147', 'Typical absence seizure', 'MP:0005403', 'abnormal nerve conduction', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(267010, 'HP:0011147', 'Typical absence seizure', 'MP:0003482', 'increased nerve fiber response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(267011, 'HP:0011147', 'Typical absence seizure', 'MP:0001985', 'abnormal gustatory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267012, 'HP:0011147', 'Typical absence seizure', 'MP:0010680', 'abnormal skin adnexa physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267013, 'HP:0011147', 'Typical absence seizure', 'MP:0000921', 'demyelination', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(267014, 'HP:0011147', 'Typical absence seizure', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267015, 'HP:0011147', 'Typical absence seizure', 'MP:0011994', 'increased nerve conduction velocity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(267016, 'HP:0011147', 'Typical absence seizure', 'MP:0005445', 'abnormal neurotransmitter secretion', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(267017, 'HP:0011147', 'Typical absence seizure', 'MP:0003996', 'clonic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(267018, 'HP:0011147', 'Typical absence seizure', 'MP:0002133', 'abnormal respiratory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267019, 'HP:0011147', 'Typical absence seizure', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267020, 'HP:0011147', 'Typical absence seizure', 'MP:0002164', 'abnormal gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267021, 'HP:0011147', 'Typical absence seizure', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(267022, 'HP:0011147', 'Typical absence seizure', 'MP:0006082', 'CNS inflammation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(267023, 'HP:0011147', 'Typical absence seizure', 'MP:0003216', 'absence seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(267024, 'HP:0011147', 'Typical absence seizure', 'MP:0004513', 'avnosmia', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(267025, 'HP:0011147', 'Typical absence seizure', 'MP:0003889', 'enhanced sensorimotor gating', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(267026, 'HP:0011147', 'Typical absence seizure', 'MP:0003481', 'decreased nerve fiber response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(267027, 'HP:0011147', 'Typical absence seizure', 'MP:0011397', 'endoneurial edema', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(267028, 'HP:0011147', 'Typical absence seizure', 'MP:0003088', 'abnormal prepulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(267029, 'HP:0011147', 'Typical absence seizure', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267030, 'HP:0011147', 'Typical absence seizure', 'MP:0005447', 'abnormal synaptic norepinephrine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(267031, 'HP:0011147', 'Typical absence seizure', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267032, 'HP:0011147', 'Typical absence seizure', 'MP:0002910', 'abnormal excitatory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(267033, 'HP:0011147', 'Typical absence seizure', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(267034, 'HP:0011147', 'Typical absence seizure', 'MP:0021010', 'impaired synaptic physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(267035, 'HP:0011147', 'Typical absence seizure', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(267036, 'HP:0011147', 'Typical absence seizure', 'MP:0002913', 'abnormal PNS synaptic transmission', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(267037, 'HP:0011147', 'Typical absence seizure', 'MP:0009358', 'environmentally induced seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(267038, 'HP:0011147', 'Typical absence seizure', 'MP:0031092', 'dysgeusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267039, 'HP:0011147', 'Typical absence seizure', 'MP:0003472', 'increased summary potential threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(267040, 'HP:0011147', 'Typical absence seizure', 'MP:0004835', 'abnormal miniature endplate potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(267041, 'HP:0011147', 'Typical absence seizure', 'MP:0001984', 'abnormal olfaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267042, 'HP:0011147', 'Typical absence seizure', 'MP:0003485', 'abnormal channel response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(267043, 'HP:0011147', 'Typical absence seizure', 'MP:0014120', 'focal seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(267044, 'HP:0011147', 'Typical absence seizure', 'MP:0003480', 'increased nerve fiber response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(267045, 'HP:0030022', 'Question mark ear', 'MP:0000022', 'abnormal ear shape', 0.5813953488372093, 11.115294171581601, 2.542121226911668, 'UPHENO:0005986', 'abnormal shape of external ear'),
(267046, 'HP:0030022', 'Question mark ear', 'MP:0003677', 'abnormal ear lobe morphology', 0.4090909090909091, 10.255471829629862, 2.048272514569165, 'UPHENO:0086699', 'abnormal external ear morphology'),
(267047, 'HP:0030022', 'Question mark ear', 'MP:0020084', 'short ears', 0.40384615384615385, 10.255471829629862, 2.035100207428027, 'UPHENO:0086699', 'abnormal external ear morphology'),
(267048, 'HP:0030022', 'Question mark ear', 'MP:0000019', 'thick ears', 0.40384615384615385, 10.255471829629862, 2.035100207428027, 'UPHENO:0086699', 'abnormal external ear morphology'),
(267049, 'HP:0030022', 'Question mark ear', 'MP:0000020', 'scaly ears', 0.4186046511627907, 10.255471829629862, 2.0719527522972223, 'UPHENO:0086699', 'abnormal external ear morphology'),
(267050, 'HP:0030022', 'Question mark ear', 'MP:0003735', 'cup-shaped ears', 0.5102040816326531, 11.115294171581601, 2.381400523828063, 'UPHENO:0005986', 'abnormal shape of external ear'),
(267051, 'HP:0030022', 'Question mark ear', 'MP:0011495', 'abnormal head shape', 0.47619047619047616, 6.5236679405794336, 1.7625290190896328, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(267052, 'HP:0030022', 'Question mark ear', 'MP:0003681', 'protruding ear lobes', 0.40425531914893614, 10.255471829629862, 2.036130898913413, 'UPHENO:0086699', 'abnormal external ear morphology'),
(267053, 'HP:0030022', 'Question mark ear', 'MP:0020290', 'floppy ears', 0.4186046511627907, 10.255471829629862, 2.0719527522972223, 'UPHENO:0086699', 'abnormal external ear morphology'),
(267054, 'HP:0030022', 'Question mark ear', 'MP:0003713', 'abnormal ear rotation', 0.42, 10.255471829629862, 2.0754031339584467, 'UPHENO:0086699', 'abnormal external ear morphology'),
(267055, 'HP:0030022', 'Question mark ear', 'MP:0030092', 'abnormal outer ear helix morphology', 0.4090909090909091, 10.255471829629862, 2.048272514569165, 'UPHENO:0086699', 'abnormal external ear morphology'),
(267056, 'HP:0030022', 'Question mark ear', 'MP:0003736', 'folded helix', 0.46296296296296297, 11.115294171581601, 2.268472949779294, 'UPHENO:0005986', 'abnormal shape of external ear'),
(267057, 'HP:0030022', 'Question mark ear', 'MP:0002177', 'abnormal outer ear morphology', 0.42857142857142855, 10.255471829629862, 2.0964737567397576, 'UPHENO:0086699', 'abnormal external ear morphology'),
(267058, 'HP:0030022', 'Question mark ear', 'MP:0030368', 'trigonocephaly', 0.4166666666666667, 6.5236679405794336, 1.6486949309200385, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(267059, 'HP:0030022', 'Question mark ear', 'MP:0003715', 'posteriorly rotated ears', 0.4117647058823529, 10.255471829629862, 2.0549553137750456, 'UPHENO:0086699', 'abnormal external ear morphology'),
(267060, 'HP:0030022', 'Question mark ear', 'MP:0000053', 'excessive ear growth', 0.42857142857142855, 10.255471829629862, 2.0964737567397576, 'UPHENO:0086699', 'abnormal external ear morphology'),
(267061, 'HP:0030022', 'Question mark ear', 'MP:0030045', 'abnormal forehead shape', 0.4166666666666667, 6.5236679405794336, 1.6486949309200385, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(267062, 'HP:0030022', 'Question mark ear', 'MP:0020085', 'long ears', 0.40384615384615385, 10.255471829629862, 2.035100207428027, 'UPHENO:0086699', 'abnormal external ear morphology'),
(267063, 'HP:0030022', 'Question mark ear', 'MP:0003712', 'raised ear position', 0.40425531914893614, 10.255471829629862, 2.036130898913413, 'UPHENO:0086699', 'abnormal external ear morphology'),
(267064, 'HP:0030022', 'Question mark ear', 'MP:0011496', 'abnormal head size', 0.40476190476190477, 4.6730878730104815, 1.3753137636915733, 'UPHENO:0087907', 'abnormal head morphology'),
(267065, 'HP:0030022', 'Question mark ear', 'MP:0003716', 'anteriorly rotated ears', 0.4117647058823529, 10.255471829629862, 2.0549553137750456, 'UPHENO:0086699', 'abnormal external ear morphology'),
(267066, 'HP:0030022', 'Question mark ear', 'MP:0000018', 'small ears', 0.44680851063829785, 10.255471829629862, 2.1406148869168264, 'UPHENO:0086699', 'abnormal external ear morphology'),
(267067, 'HP:0030022', 'Question mark ear', 'MP:0030071', 'abnormal face shape', 0.43478260869565216, 6.5236679405794336, 1.684154792609432, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(267068, 'HP:0030022', 'Question mark ear', 'MP:0003737', 'ossification of pinnae', 0.4186046511627907, 10.255471829629862, 2.0719527522972223, 'UPHENO:0086699', 'abnormal external ear morphology'),
(267069, 'HP:0030022', 'Question mark ear', 'MP:0009578', 'otocephaly', 0.46511627906976744, 6.5236679405794336, 1.7419139354196116, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(267070, 'HP:0030022', 'Question mark ear', 'MP:0030074', 'coarse facial features', 0.425531914893617, 6.5236679405794336, 1.6661419239923307, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(267071, 'HP:0030022', 'Question mark ear', 'MP:0000023', 'abnormal ear position', 0.41304347826086957, 10.255471829629862, 2.0581437645890244, 'UPHENO:0086699', 'abnormal external ear morphology'),
(267072, 'HP:0030022', 'Question mark ear', 'MP:0000017', 'big ears', 0.44680851063829785, 10.255471829629862, 2.1406148869168264, 'UPHENO:0086699', 'abnormal external ear morphology'),
(267073, 'HP:0030022', 'Question mark ear', 'MP:0006290', 'proboscis', 0.46511627906976744, 6.5236679405794336, 1.7419139354196116, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(267074, 'HP:0030022', 'Question mark ear', 'MP:0030078', 'synotia', 0.40425531914893614, 10.255471829629862, 2.036130898913413, 'UPHENO:0086699', 'abnormal external ear morphology'),
(267075, 'HP:0100825', 'Cheilitis', 'MP:0003782', 'short lip', 0.42105263157894735, 11.249595263293193, 2.176389599728794, 'UPHENO:0020955', 'abnormal lip morphology'),
(267076, 'HP:0100825', 'Cheilitis', 'MP:0031503', 'abnormal mouth size', 0.4230769230769231, 7.503859459499253, 1.7817715261297131, 'UPHENO:0076800', 'abnormal mouth morphology'),
(267077, 'HP:0100825', 'Cheilitis', 'MP:0003773', 'eclabion', 0.4444444444444444, 11.249595263293193, 2.236027754080704, 'UPHENO:0020955', 'abnormal lip morphology'),
(267078, 'HP:0100825', 'Cheilitis', 'MP:0003775', 'thin lip', 0.42105263157894735, 11.249595263293193, 2.176389599728794, 'UPHENO:0020955', 'abnormal lip morphology'),
(267079, 'HP:0100825', 'Cheilitis', 'MP:0003774', 'thick lip', 0.41379310344827586, 11.249595263293193, 2.157546045055612, 'UPHENO:0020955', 'abnormal lip morphology'),
(267080, 'HP:0100825', 'Cheilitis', 'MP:0003776', 'lip atrophy', 0.42857142857142855, 11.249595263293193, 2.19573566552077, 'UPHENO:0020955', 'abnormal lip morphology'),
(267081, 'HP:0100825', 'Cheilitis', 'MP:0003771', 'abnormal lip shape', 0.42857142857142855, 11.249595263293193, 2.19573566552077, 'UPHENO:0020955', 'abnormal lip morphology'),
(267082, 'HP:0100825', 'Cheilitis', 'MP:0009576', 'oral atresia', 0.41509433962264153, 7.503859459499253, 1.7648823153292557, 'UPHENO:0076800', 'abnormal mouth morphology'),
(267083, 'HP:0100825', 'Cheilitis', 'MP:0009881', 'increased mouth size', 0.41509433962264153, 7.503859459499253, 1.7648823153292557, 'UPHENO:0076800', 'abnormal mouth morphology'),
(267084, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0009610', 'abnormal epidermis stratum lucidum morphology', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267085, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0009931', 'abnormal skin appearance', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267086, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0008856', 'fetal bleb', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267087, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0001193', 'psoriasis', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267088, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0009563', 'dyskeratosis', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267089, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0009379', 'abnormal foot pigmentation', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267090, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0009387', 'abnormal epidermal pigmentation', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267091, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0009385', 'abnormal dermal pigmentation', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267092, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0009441', 'delayed skin barrier formation', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267093, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0008816', 'petechiae', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267094, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0008438', 'abnormal cutaneous collagen fibril morphology', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267095, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0001208', 'blistering', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267096, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0001239', 'abnormal epidermis stratum granulosum morphology', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267097, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0002060', 'abnormal skin morphology', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267098, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0011160', 'dermal-epidermal separation', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267099, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0009827', 'skin detachment', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267100, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0011239', 'abnormal skin coloration', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267101, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0010206', 'pigment incontinence', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267102, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0001243', 'abnormal dermal layer morphology', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267103, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0001216', 'abnormal epidermal layer morphology', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267104, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0001236', 'abnormal epidermis stratum spinosum morphology', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267105, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0011515', 'purpura', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267106, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0001198', 'tight skin', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267107, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0013406', 'abnormal epidermal immune compartment', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267108, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0003853', 'dry skin', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267109, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0001210', 'skin ridges', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267110, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0001246', 'mixed cellular infiltration to dermis', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267111, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0003652', 'abnormal skin turgor', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267112, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0012078', 'abnormal tail ring morphology', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267113, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0008418', 'abnormal cutaneous elastic fiber morphology', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267114, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0001196', 'shiny skin', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267115, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0001191', 'abnormal skin condition', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267116, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0002897', 'blotchy skin', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267117, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0003653', 'decreased skin turgor', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267118, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0001209', 'spontaneous skin ulceration', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267119, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0001212', 'skin lesions', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267120, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0001192', 'scaly skin', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267121, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0005421', 'loose skin', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267122, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0003941', 'abnormal skin development', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267123, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0011159', 'abnormal epidermal-dermal junction morphology', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267124, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0001230', 'epidermal desquamation', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267125, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0003717', 'pallor', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267126, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0010016', 'variable depigmentation', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267127, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0001231', 'abnormal epidermis stratum basale morphology', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267128, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0010232', 'delayed skin pigmentation appearance', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267129, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0008854', 'bleb', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267130, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0031103', 'skin rash', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267131, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0001195', 'flaky skin', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267132, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0001213', 'abnormal skin cell number', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267133, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0003940', 'abnormal dermatome morphology', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267134, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0001201', 'translucent skin', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267135, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0002095', 'abnormal skin pigmentation', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267136, 'HP:0007549', 'Desquamation of skin soon after birth', 'MP:0001233', 'abnormal epidermis suprabasal layer morphology', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(267137, 'HP:0100692', 'Increased corneal curvature', 'MP:0005193', 'abnormal anterior eye segment morphology', 0.40816326530612246, 8.423925443855504, 1.854275307460947, 'UPHENO:0087597', 'abnormal anterior segment of eyeball morphology'),
(267138, 'HP:0100692', 'Increased corneal curvature', 'MP:0012121', 'sclerocornea', 0.41509433962264153, 10.417322709031257, 2.0794642796983256, 'UPHENO:0087577', 'abnormal cornea morphology'),
(267139, 'HP:0100692', 'Increased corneal curvature', 'MP:0001314', 'corneal opacity', 0.4230769230769231, 10.417322709031257, 2.099363912816523, 'UPHENO:0087577', 'abnormal cornea morphology'),
(267140, 'HP:0100692', 'Increased corneal curvature', 'MP:0008841', 'ruptured lens capsule', 0.4107142857142857, 8.423925443855504, 1.8600608919020662, 'UPHENO:0087597', 'abnormal anterior segment of eyeball morphology'),
(267141, 'HP:0100692', 'Increased corneal curvature', 'MP:0001305', 'enlarged lens', 0.4107142857142857, 8.423925443855504, 1.8600608919020662, 'UPHENO:0087597', 'abnormal anterior segment of eyeball morphology'),
(267142, 'HP:0100692', 'Increased corneal curvature', 'MP:0031176', 'abnormal Descemet membrane thickness', 0.43103448275862066, 10.417322709031257, 2.119015173522106, 'UPHENO:0087577', 'abnormal cornea morphology'),
(267143, 'HP:0100692', 'Increased corneal curvature', 'MP:0020857', 'corneal epithelium hyperplasia', 0.4166666666666667, 10.417322709031257, 2.0833989365368852, 'UPHENO:0087577', 'abnormal cornea morphology'),
(267144, 'HP:0100692', 'Increased corneal curvature', 'MP:0010713', 'corneal-lenticular stalk', 0.4074074074074074, 10.417322709031257, 2.060120005488208, 'UPHENO:0087577', 'abnormal cornea morphology'),
(267145, 'HP:0100692', 'Increased corneal curvature', 'MP:0006209', 'calcified intraocular region', 0.43137254901960786, 8.581084971325078, 1.9239658254330683, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(267146, 'HP:0100692', 'Increased corneal curvature', 'MP:0014131', 'abnormal tear film morphology', 0.4117647058823529, 9.656834392011628, 1.994077123177852, 'UPHENO:0087232', 'abnormal ocular surface region morphology'),
(267147, 'HP:0100692', 'Increased corneal curvature', 'MP:0012353', 'bilateral cornea degeneration', 0.4642857142857143, 11.115294171581601, 2.2717113139544383, 'UPHENO:0020998', 'abnormal cornea morphology'),
(267148, 'HP:0100692', 'Increased corneal curvature', 'MP:0009829', 'enlarged eye anterior chamber', 0.40350877192982454, 8.423925443855504, 1.8436723707531488, 'UPHENO:0087597', 'abnormal anterior segment of eyeball morphology'),
(267149, 'HP:0100692', 'Increased corneal curvature', 'MP:0031500', 'increased cornea size', 0.4482758620689655, 11.115294171581601, 2.2322002770620495, 'UPHENO:0020998', 'abnormal cornea morphology'),
(267150, 'HP:0100692', 'Increased corneal curvature', 'MP:0011961', 'abnormal cornea thickness', 0.45614035087719296, 11.115294171581601, 2.2516958461409593, 'UPHENO:0020998', 'abnormal cornea morphology'),
(267151, 'HP:0100692', 'Increased corneal curvature', 'MP:0005544', 'corneal deposits', 0.4230769230769231, 10.417322709031257, 2.099363912816523, 'UPHENO:0087577', 'abnormal cornea morphology'),
(267152, 'HP:0100692', 'Increased corneal curvature', 'MP:0006225', 'ocular rupture', 0.43137254901960786, 8.581084971325078, 1.9239658254330683, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(267153, 'HP:0100692', 'Increased corneal curvature', 'MP:0009825', 'cornea ulcer', 0.4230769230769231, 10.417322709031257, 2.099363912816523, 'UPHENO:0087577', 'abnormal cornea morphology'),
(267154, 'HP:0100692', 'Increased corneal curvature', 'MP:0012352', 'progressive cornea degeneration', 0.4642857142857143, 11.115294171581601, 2.2717113139544383, 'UPHENO:0020998', 'abnormal cornea morphology'),
(267155, 'HP:0100692', 'Increased corneal curvature', 'MP:0001312', 'abnormal cornea morphology', 0.43137254901960786, 10.417322709031257, 2.119845996990031, 'UPHENO:0087577', 'abnormal cornea morphology'),
(267156, 'HP:0100692', 'Increased corneal curvature', 'MP:0001306', 'small lens', 0.4107142857142857, 8.423925443855504, 1.8600608919020662, 'UPHENO:0087597', 'abnormal anterior segment of eyeball morphology'),
(267157, 'HP:0100692', 'Increased corneal curvature', 'MP:0012351', 'cornea degeneration', 0.4727272727272727, 11.115294171581601, 2.292270206431415, 'UPHENO:0020998', 'abnormal cornea morphology'),
(267158, 'HP:0100692', 'Increased corneal curvature', 'MP:0006000', 'abnormal corneal epithelium morphology', 0.41509433962264153, 10.417322709031257, 2.0794642796983256, 'UPHENO:0087577', 'abnormal cornea morphology'),
(267159, 'HP:0100692', 'Increased corneal curvature', 'MP:0005301', 'abnormal corneal endothelium morphology', 0.41509433962264153, 10.417322709031257, 2.0794642796983256, 'UPHENO:0087577', 'abnormal cornea morphology'),
(267160, 'HP:0100692', 'Increased corneal curvature', 'MP:0005176', 'eyelids fail to open', 0.4074074074074074, 8.581084971325078, 1.8697586959044252, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(267161, 'HP:0100692', 'Increased corneal curvature', 'MP:0001316', 'corneal scarring', 0.4230769230769231, 10.417322709031257, 2.099363912816523, 'UPHENO:0087577', 'abnormal cornea morphology'),
(267162, 'HP:0100692', 'Increased corneal curvature', 'MP:0031432', 'cornea perforation', 0.48148148148148145, 11.115294171581601, 2.313397567396401, 'UPHENO:0020998', 'abnormal cornea morphology'),
(267163, 'HP:0100692', 'Increased corneal curvature', 'MP:0008521', 'abnormal Bowman membrane morphology', 0.41509433962264153, 10.417322709031257, 2.0794642796983256, 'UPHENO:0087577', 'abnormal cornea morphology'),
(267164, 'HP:0100692', 'Increased corneal curvature', 'MP:0031317', 'spherophakia', 0.40350877192982454, 8.423925443855504, 1.8436723707531488, 'UPHENO:0087597', 'abnormal anterior segment of eyeball morphology'),
(267165, 'HP:0100692', 'Increased corneal curvature', 'MP:0031498', 'abnormal cornea size', 0.48148148148148145, 11.115294171581601, 2.313397567396401, 'UPHENO:0020998', 'abnormal cornea morphology'),
(267166, 'HP:0100692', 'Increased corneal curvature', 'MP:0009742', 'increased corneal stroma thickness', 0.4098360655737705, 10.417322709031257, 2.0662513285855773, 'UPHENO:0087577', 'abnormal cornea morphology'),
(267167, 'HP:0100692', 'Increased corneal curvature', 'MP:0005543', 'decreased cornea thickness', 0.40625, 11.115294171581601, 2.12499135461889, 'UPHENO:0020998', 'abnormal cornea morphology'),
(267168, 'HP:0100692', 'Increased corneal curvature', 'MP:0031499', 'decreased cornea size', 0.4482758620689655, 11.115294171581601, 2.2322002770620495, 'UPHENO:0020998', 'abnormal cornea morphology'),
(267169, 'HP:0100692', 'Increased corneal curvature', 'MP:0020859', 'disorganized corneal epithelium', 0.43859649122807015, 10.417322709031257, 2.137522207644076, 'UPHENO:0087577', 'abnormal cornea morphology'),
(267170, 'HP:0100692', 'Increased corneal curvature', 'MP:0004105', 'corneal abrasion', 0.4230769230769231, 10.417322709031257, 2.099363912816523, 'UPHENO:0087577', 'abnormal cornea morphology'),
(267171, 'HP:0100692', 'Increased corneal curvature', 'MP:0020853', 'abnormal corneal epithelium thickness', 0.43103448275862066, 10.417322709031257, 2.119015173522106, 'UPHENO:0087577', 'abnormal cornea morphology'),
(267172, 'HP:0100692', 'Increased corneal curvature', 'MP:0001307', 'fused cornea and lens', 0.4262295081967213, 11.115294171581601, 2.1766181034382464, 'UPHENO:0020998', 'abnormal cornea morphology'),
(267173, 'HP:0100692', 'Increased corneal curvature', 'MP:0002697', 'abnormal eye size', 0.43137254901960786, 8.581084971325078, 1.9239658254330683, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(267174, 'HP:0100692', 'Increased corneal curvature', 'MP:0004284', 'abnormal Descemet membrane morphology', 0.41509433962264153, 10.417322709031257, 2.0794642796983256, 'UPHENO:0087577', 'abnormal cornea morphology'),
(267175, 'HP:0100692', 'Increased corneal curvature', 'MP:0005300', 'abnormal corneal stroma morphology', 0.41509433962264153, 10.417322709031257, 2.0794642796983256, 'UPHENO:0087577', 'abnormal cornea morphology'),
(267176, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0010680', 'abnormal skin adnexa physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267177, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0004010', 'increased diastolic filling velocity', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267178, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0003549', 'pulmonary hypotension', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267179, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0002161', 'abnormal fertility/fecundity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267180, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0010553', 'prolonged HV interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267181, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0000233', 'abnormal blood flow velocity', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267182, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0008775', 'abnormal heart ventricle pressure', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267183, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0003042', 'decreased time of onset of induced ischemic contracture', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267184, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0001985', 'abnormal gustatory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267185, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0013636', 'abnormal bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267186, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0011928', 'abnormal mitral valve flow', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267187, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0000350', 'abnormal cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267188, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0011918', 'abnormal PQ interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267189, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0001986', 'abnormal taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267190, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0011951', 'increased cardiac stroke volume', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267191, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267192, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0000343', 'abnormal response to cardiac infarction', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267193, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0003298', 'choking', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267194, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0012685', 'abnormal primitive streak elongation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267195, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0001984', 'abnormal olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267196, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0031216', 'decreased susceptibility to myocardial ischemic injury', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267197, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0008817', 'hematoma', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267198, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0002723', 'abnormal immune serum protein physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267199, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0011920', 'abnormal S wave', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267200, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0011927', 'abnormal cardiac valve flow', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267201, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0020096', 'high mean heart rate adaptation', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267202, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0003823', 'increased left ventricle developed pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267203, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0001636', 'irregular heartbeat', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267204, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267205, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0002998', 'abnormal bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267206, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0010554', 'shortened HV interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267207, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0010756', 'decreased right ventricle peak pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267208, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0031092', 'dysgeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267209, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0004512', 'anosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267210, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0010512', 'absent PR interval', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267211, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267212, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267213, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0003039', 'increased time of peak ischemic contracture', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267214, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0004484', 'abnormal response of heart to induced stress', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267215, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0010506', 'prolonged RR interval', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267216, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0011937', 'shortened PP interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267217, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0010513', 'abnormal ventricular activation time', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267218, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0005330', 'cardiomyopathy', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267219, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0010514', 'fragmented QRS complex', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267220, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0031215', 'abnormal response to myocardial ischemic injury', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267221, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0010519', 'atrioventricular block', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267222, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267223, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0012046', 'decreased susceptibility to hypertension', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267224, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0003633', 'abnormal nervous system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267225, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0003033', 'abnormal pulmonary vascular resistance', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267226, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0031302', 'syncope', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267227, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0004156', 'abnormal QT variability', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267228, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0004086', 'absent heartbeat', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267229, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0001947', 'abnormal mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267230, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0010504', 'abnormal RR interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267231, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0004486', 'decreased response of heart to induced stress', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267232, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0004013', 'decreased pulmonary artery pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267233, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0001598', 'abnormal blood viscosity', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267234, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0003868', 'abnormal feces composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267235, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0006265', 'increased pulse pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267236, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0003875', 'abnormal hair follicle regression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267237, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0003880', 'abnormal central pattern generator function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267238, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0004879', 'decreased systemic vascular resistance', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267239, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0004875', 'increased mean systemic arterial blood pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267240, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267241, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0010392', 'prolonged QRS complex duration', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267242, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0013135', 'poor circulation in tail', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267243, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267244, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0004211', 'abnormal sour taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267245, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0003897', 'abnormal ST segment', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267246, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0003896', 'prolonged PR interval', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267247, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0002420', 'abnormal adaptive immunity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267248, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0031136', 'muscle hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267249, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0001983', 'abnormal olfactory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267250, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0006047', 'aortic valve regurgitation', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267251, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0002133', 'abnormal respiratory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267252, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0003394', 'increased cardiac output', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267253, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0004217', 'salt-sensitive hypertension', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267254, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0004012', 'increased pulmonary artery pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267255, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267256, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0031129', 'left-to-right shunt', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267257, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0003899', 'abnormal QT interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267258, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0010511', 'shortened PR interval', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267259, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0002164', 'abnormal gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267260, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0004877', 'abnormal systemic vascular resistance', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267261, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267262, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0001756', 'abnormal urination', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267263, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0010377', 'abnormal gut flora balance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267264, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0006054', 'spinal hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267265, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0009275', 'bruising', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267266, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0020846', 'abnormal cell motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267267, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0010393', 'shortened QRS complex duration', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267268, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0009384', 'cardiac valve regurgitation', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267269, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0005532', 'abnormal vascular resistance', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267270, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0010695', 'abnormal blood pressure regulation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267271, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0000231', 'hypertension', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267272, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0011043', 'abnormal lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267273, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0002972', 'abnormal cardiac muscle contractility', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267274, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0004011', 'decreased diastolic filling velocity', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267275, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0001533', 'abnormal skeleton physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267276, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0009698', 'heart hemorrhage', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267277, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267278, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0001845', 'abnormal inflammatory response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267279, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0006111', 'abnormal coronary circulation', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267280, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0003901', 'abnormal PR interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267281, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0004072', 'abnormal frontal plane axis', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267282, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267283, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0006143', 'increased systemic arterial diastolic blood pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267284, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0003820', 'increased left ventricle systolic pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267285, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0013134', 'poor circulation in autopods', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267286, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0006138', 'congestive heart failure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267287, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0010637', 'sinus bradycardia', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267288, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267289, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0002952', 'ventricular cardiomyopathy', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267290, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267291, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0010994', 'aerophagia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267292, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0011952', 'decreased cardiac stroke volume', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267293, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0013136', 'genital discharge', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267294, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0001835', 'abnormal antigen presentation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267295, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0006144', 'increased systemic arterial systolic blood pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267296, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0003929', 'decreased heart rate variability', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267297, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267298, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0004485', 'increased response of heart to induced stress', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267299, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0004245', 'genital hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267300, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0020000', 'abnormal response to antigen', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267301, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0011929', 'abnormal aortic valve flow', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267302, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0002421', 'abnormal cell-mediated immunity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267303, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267304, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0008861', 'abnormal hair shedding', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267305, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0004084', 'abnormal cardiac muscle relaxation', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267306, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0020419', 'decreased cardiac muscle relaxation', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267307, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0010950', 'abnormal lung hysteresivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267308, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0005410', 'abnormal fertilization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267309, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0005333', 'decreased heart rate', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267310, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0003882', 'abnormal pulse pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267311, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0001599', 'abnormal blood volume', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267312, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0003898', 'abnormal QRS complex', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267313, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0003186', 'abnormal redox activity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267314, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0002626', 'increased heart rate', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267315, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267316, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0011930', 'abnormal tricuspid valve flow', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267317, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0011931', 'abnormal pulmonary valve flow', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267318, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0011925', 'abnormal heart echocardiography feature', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267319, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0012382', 'abnormal blood cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267320, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267321, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267322, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0006048', 'pulmonary valve regurgitation', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267323, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0001633', 'poor circulation', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267324, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0006046', 'atrioventricular valve regurgitation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267325, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0012558', 'increased calcium uptake by cardiac muscle', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267326, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0003824', 'decreased left ventricle developed pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267327, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0004558', 'delayed allantois development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267328, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0006044', 'tricuspid valve regurgitation', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267329, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267330, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0010571', 'shortened ST segment', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267331, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0011514', 'skin hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267332, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0011390', 'abnormal fetal cardiomyocyte physiology', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267333, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0010509', 'decreased P wave amplitude', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267334, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0002128', 'abnormal blood circulation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267335, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0001627', 'abnormal cardiac output', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267336, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0011938', 'prolonged PP interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267337, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0020097', 'low mean heart rate adaptation', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267338, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267339, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0013559', 'abnormal exocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267340, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0031192', 'coronary artery spasm', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267341, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0008271', 'abnormal bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267342, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0011954', 'shortened PQ interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267343, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0031090', 'ageusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267344, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0030988', 'dysosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267345, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0004212', 'abnormal salty taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267346, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0009732', 'ventricular premature beat', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267347, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0010520', 'sinoatrial block', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267348, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0002419', 'abnormal innate immunity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267349, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0003900', 'shortened QT interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267350, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0009697', 'abnormal copulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267351, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0031089', 'sneezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267352, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0001914', 'hemorrhage', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267353, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0005599', 'increased cardiac muscle contractility', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267354, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267355, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267356, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0010510', 'absent P wave', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267357, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0001790', 'abnormal immune system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267358, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267359, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0011046', 'abnormal lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267360, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267361, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0010758', 'increased right ventricle systolic pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267362, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267363, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0010822', 'pneumothorax', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267364, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0004145', 'abnormal muscle electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267365, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0002842', 'increased systemic arterial blood pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267366, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0001915', 'intracranial hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267367, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0004876', 'decreased mean systemic arterial blood pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267368, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0011953', 'prolonged PQ interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267369, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0001800', 'abnormal humoral immune response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267370, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0001629', 'abnormal heart rate', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267371, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0012557', 'decreased calcium uptake by cardiac muscle', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267372, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0004878', 'increased systemic vascular resistance', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267373, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0003037', 'increased myocardial infarct size', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267374, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267375, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0009046', 'muscle twitch', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267376, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267377, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0031098', 'abnormal sputum production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267378, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267379, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0014020', 'intramural bleeding in blood vessel wall', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267380, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267381, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0005621', 'abnormal cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267382, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0031170', 'abnormal vasculature physiology', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267383, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0006045', 'mitral valve regurgitation', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267384, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0001943', 'abnormal respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267385, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0001596', 'hypotension', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267386, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267387, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0012045', 'increased susceptibility to hypertension', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267388, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267389, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0031091', 'hypogeusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267390, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267391, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0031128', 'cardiovascular shunt', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267392, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267393, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0011919', 'abnormal R wave', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267394, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0010570', 'prolonged ST segment', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267395, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0031102', 'rhinorrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267396, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0004070', 'abnormal P wave', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267397, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267398, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0031088', 'coughing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267399, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0003548', 'pulmonary hypertension', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267400, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0004085', 'abnormal heartbeat', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267401, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0010559', 'heart block', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267402, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267403, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0008004', 'abnormal stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267404, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0001919', 'abnormal reproductive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267405, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0001864', 'vascular inflammation', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267406, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267407, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0006049', 'semilunar valve regurgitation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267408, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0010634', 'increased QRS amplitude', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267409, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0013127', 'epistaxis', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267410, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0000423', 'delayed hair regrowth', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267411, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0020345', 'abnormal myocardial fiber currents', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267412, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0003040', 'decreased time of peak ischemic contracture', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267413, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0002634', 'abnormal sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267414, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0005000', 'abnormal immune tolerance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267415, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0000313', 'abnormal cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267416, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0003566', 'abnormal cell adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267417, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0003547', 'abnormal pulmonary pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267418, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0020346', 'abnormal myocardial fiber calcium currents', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267419, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0031130', 'right-to-left shunt', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267420, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0006264', 'decreased systemic arterial systolic blood pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267421, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0010552', 'abnormal HV interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267422, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0004142', 'abnormal muscle tone', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267423, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0005666', 'abnormal adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267424, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0004071', 'prolonged P wave', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267425, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0004036', 'abnormal muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267426, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0005435', 'hemoperitoneum', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267427, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0000304', 'abnormal cardiac stroke volume', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267428, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0010631', 'increased Q wave amplitude', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267429, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0003035', 'decreased pulmonary vascular resistance', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267430, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0031402', 'decreased muscle fatigability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267431, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0004215', 'abnormal myocardial fiber physiology', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267432, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0010394', 'decreased QRS amplitude', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267433, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0005620', 'abnormal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267434, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0000465', 'gastrointestinal hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267435, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0010507', 'shortened RR interval', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267436, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267437, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0000427', 'abnormal hair cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267438, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0011082', 'abnormal gastrointestinal motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267439, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0002106', 'abnormal muscle physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267440, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0005076', 'abnormal cell differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267441, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0001634', 'internal hemorrhage', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267442, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267443, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267444, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0000249', 'abnormal blood vessel physiology', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267445, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0008950', 'ventricular tachycardia', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267446, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0031217', 'increased susceptibility to myocardial ischemic injury', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267447, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0004213', 'abnormal umami taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267448, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0003438', 'abnormal carotid body physiology', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267449, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0011022', 'abnormal circadian regulation of systemic arterial blood pressure', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267450, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0004122', 'abnormal sinus arrhythmia', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267451, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0020412', 'abnormal amnion physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267452, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0020418', 'increased cardiac muscle relaxation', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267453, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0004216', 'salt-resistant hypertension', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267454, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0005501', 'abnormal skin physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267455, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0003041', 'increased time of onset of induced ischemic contracture', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267456, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0003928', 'increased heart rate variability', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267457, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267458, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0005671', 'abnormal response to transplant', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267459, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0031152', 'subcutaneous hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267460, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267461, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0003393', 'decreased cardiac output', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267462, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0003925', 'abnormal cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267463, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267464, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267465, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0009562', 'abnormal odor adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267466, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0006266', 'decreased pulse pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267467, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267468, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267469, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0008544', 'impaired olfaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267470, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0010516', 'absent Q wave', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267471, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0001663', 'abnormal digestive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267472, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0006080', 'brain ischemia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267473, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0010515', 'abnormal Q wave', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267474, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0001542', 'abnormal bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267475, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267476, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267477, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0011926', 'abnormal heart valve physiology', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267478, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267479, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0010560', 'intraventricular block', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267480, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0010636', 'bundle branch block', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267481, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0020347', 'abnormal myocardial fiber sodium currents', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267482, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267483, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0003233', 'prolonged QT interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267484, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0000751', 'myopathy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267485, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0013806', 'encephalopathy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267486, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0011936', 'abnormal PP interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267487, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0003034', 'increased pulmonary vascular resistance', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267488, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0008776', 'increased right ventricle peak pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267489, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0004009', 'abnormal diastolic filling velocity', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267490, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0003077', 'abnormal cell cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267491, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0003038', 'decreased myocardial infarct size', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267492, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0006114', 'cardiac murmur', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267493, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0001664', 'abnormal digestion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267494, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0010505', 'abnormal T wave', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267495, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267496, 'HP:0006684', 'Ventricular preexcitation with multiple accessory pathways', 'MP:0006263', 'decreased systemic arterial diastolic blood pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(267497, 'HP:0002614', 'Hepatic periportal necrosis', 'MP:0000601', 'small liver', 0.4444444444444444, 10.450642782231284, 2.155163595979694, 'UPHENO:0019492', 'abnormal liver morphology'),
(267498, 'HP:0002614', 'Hepatic periportal necrosis', 'MP:0010912', 'herniated liver', 0.4117647058823529, 9.291242960651683, 1.9559667494551696, 'UPHENO:0086622', 'abnormal liver morphology'),
(267499, 'HP:0002614', 'Hepatic periportal necrosis', 'MP:0003103', 'liver degeneration', 0.47058823529411764, 10.450642782231284, 2.2176450447669547, 'UPHENO:0019492', 'abnormal liver morphology'),
(267500, 'HP:0002614', 'Hepatic periportal necrosis', 'MP:0031115', 'macrovesicular hepatic steatosis', 0.40816326530612246, 9.291242960651683, 1.9473941731380722, 'UPHENO:0086622', 'abnormal liver morphology'),
(267501, 'HP:0002614', 'Hepatic periportal necrosis', 'MP:0031266', 'decreased susceptibility to alcohol-induced hepatic steatosis', 0.40816326530612246, 9.291242960651683, 1.9473941731380722, 'UPHENO:0086622', 'abnormal liver morphology'),
(267502, 'HP:0002614', 'Hepatic periportal necrosis', 'MP:0004848', 'abnormal liver size', 0.48, 10.450642782231284, 2.239711708115805, 'UPHENO:0019492', 'abnormal liver morphology'),
(267503, 'HP:0002614', 'Hepatic periportal necrosis', 'MP:0031268', 'decreased susceptibility to diet-induced hepatic steatosis', 0.40816326530612246, 9.291242960651683, 1.9473941731380722, 'UPHENO:0086622', 'abnormal liver morphology'),
(267504, 'HP:0002614', 'Hepatic periportal necrosis', 'MP:0000599', 'enlarged liver', 0.4067796610169492, 10.450642782231284, 2.0618217499011084, 'UPHENO:0019492', 'abnormal liver morphology'),
(267505, 'HP:0002614', 'Hepatic periportal necrosis', 'MP:0031116', 'microvesicular hepatic steatosis', 0.40816326530612246, 9.291242960651683, 1.9473941731380722, 'UPHENO:0086622', 'abnormal liver morphology'),
(267506, 'HP:0002614', 'Hepatic periportal necrosis', 'MP:0000603', 'pale liver', 0.4166666666666667, 9.291242960651683, 1.9675749626392556, 'UPHENO:0086622', 'abnormal liver morphology'),
(267507, 'HP:0002614', 'Hepatic periportal necrosis', 'MP:0003332', 'liver abscess', 0.4166666666666667, 9.291242960651683, 1.9675749626392556, 'UPHENO:0086622', 'abnormal liver morphology'),
(267508, 'HP:0002614', 'Hepatic periportal necrosis', 'MP:0003333', 'liver fibrosis', 0.48, 10.450642782231284, 2.239711708115805, 'UPHENO:0019492', 'abnormal liver morphology'),
(267509, 'HP:0002614', 'Hepatic periportal necrosis', 'MP:0031267', 'increased susceptibility to alcohol-induced hepatic steatosis', 0.40816326530612246, 9.291242960651683, 1.9473941731380722, 'UPHENO:0086622', 'abnormal liver morphology'),
(267510, 'HP:0002614', 'Hepatic periportal necrosis', 'MP:0002310', 'decreased susceptibility to hepatic steatosis', 0.4166666666666667, 9.291242960651683, 1.9675749626392556, 'UPHENO:0086622', 'abnormal liver morphology'),
(267511, 'HP:0002614', 'Hepatic periportal necrosis', 'MP:0008986', 'abnormal liver parenchyma morphology', 0.40816326530612246, 9.291242960651683, 1.9473941731380722, 'UPHENO:0086622', 'abnormal liver morphology'),
(267512, 'HP:0002614', 'Hepatic periportal necrosis', 'MP:0001654', 'hepatic necrosis', 0.41379310344827586, 10.450642782231284, 2.0795201152883345, 'UPHENO:0019492', 'abnormal liver morphology'),
(267513, 'HP:0002614', 'Hepatic periportal necrosis', 'MP:0002628', 'hepatic steatosis', 0.4166666666666667, 9.291242960651683, 1.9675749626392556, 'UPHENO:0086622', 'abnormal liver morphology'),
(267514, 'HP:0002614', 'Hepatic periportal necrosis', 'MP:0000598', 'abnormal liver morphology', 0.425531914893617, 9.291242960651683, 1.98839644155484, 'UPHENO:0086622', 'abnormal liver morphology'),
(267515, 'HP:0002614', 'Hepatic periportal necrosis', 'MP:0031270', 'decreased susceptibility to age-related hepatic steatosis', 0.40816326530612246, 9.291242960651683, 1.9473941731380722, 'UPHENO:0086622', 'abnormal liver morphology'),
(267516, 'HP:0002614', 'Hepatic periportal necrosis', 'MP:0031269', 'increased susceptibility to diet-induced hepatic steatosis', 0.40816326530612246, 9.291242960651683, 1.9473941731380722, 'UPHENO:0086622', 'abnormal liver morphology'),
(267517, 'HP:0002614', 'Hepatic periportal necrosis', 'MP:0001655', 'multifocal hepatic necrosis', 0.4067796610169492, 10.450642782231284, 2.0618217499011084, 'UPHENO:0019492', 'abnormal liver morphology'),
(267518, 'HP:0002614', 'Hepatic periportal necrosis', 'MP:0000600', 'liver hypoplasia', 0.4067796610169492, 10.450642782231284, 2.0618217499011084, 'UPHENO:0019492', 'abnormal liver morphology'),
(267519, 'HP:0002614', 'Hepatic periportal necrosis', 'MP:0004847', 'abnormal liver weight', 0.4528301886792453, 10.450642782231284, 2.1754003178489207, 'UPHENO:0019492', 'abnormal liver morphology'),
(267520, 'HP:0002614', 'Hepatic periportal necrosis', 'MP:0031265', 'increased susceptibility to hepatic steatosis', 0.4166666666666667, 9.291242960651683, 1.9675749626392556, 'UPHENO:0086622', 'abnormal liver morphology'),
(267521, 'HP:0002614', 'Hepatic periportal necrosis', 'MP:0005151', 'diffuse hepatic necrosis', 0.4067796610169492, 10.450642782231284, 2.0618217499011084, 'UPHENO:0019492', 'abnormal liver morphology'),
(267522, 'HP:0002614', 'Hepatic periportal necrosis', 'MP:0031271', 'increased susceptibility to age-related hepatic steatosis', 0.40816326530612246, 9.291242960651683, 1.9473941731380722, 'UPHENO:0086622', 'abnormal liver morphology'),
(267523, 'HP:0002614', 'Hepatic periportal necrosis', 'MP:0001656', 'focal hepatic necrosis', 0.4067796610169492, 10.450642782231284, 2.0618217499011084, 'UPHENO:0019492', 'abnormal liver morphology'),
(267524, 'HP:0002614', 'Hepatic periportal necrosis', 'MP:0010040', 'abnormal oval cell morphology', 0.4339622641509434, 9.291242960651683, 2.0079962230992665, 'UPHENO:0086622', 'abnormal liver morphology'),
(267525, 'HP:0002614', 'Hepatic periportal necrosis', 'MP:0003046', 'liver cirrhosis', 0.4166666666666667, 9.291242960651683, 1.9675749626392556, 'UPHENO:0086622', 'abnormal liver morphology'),
(267526, 'HP:0007874', 'Almond-shaped palpebral fissure', 'MP:0030071', 'abnormal face shape', 0.4230769230769231, 6.5236679405794336, 1.6613287933085112, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(267527, 'HP:0007874', 'Almond-shaped palpebral fissure', 'MP:0003671', 'abnormal eyelid aperture', 0.42592592592592593, 13.33412877350486, 2.3831389267666685, 'UPHENO:0003085', 'abnormal palpebral fissure'),
(267528, 'HP:0007874', 'Almond-shaped palpebral fissure', 'MP:0030045', 'abnormal forehead shape', 0.4074074074074074, 6.5236679405794336, 1.6302731803161972, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(267529, 'HP:0007874', 'Almond-shaped palpebral fissure', 'MP:0030074', 'coarse facial features', 0.41509433962264153, 6.5236679405794336, 1.6455812455519228, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(267530, 'HP:0007874', 'Almond-shaped palpebral fissure', 'MP:0006166', 'eyelid retraction', 0.41818181818181815, 13.33412877350486, 2.3613746450690027, 'UPHENO:0003085', 'abnormal palpebral fissure'),
(267531, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267532, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001986', 'abnormal taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267533, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020414', 'abnormal fibroblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267534, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002626', 'increased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267535, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001919', 'abnormal reproductive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267536, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001866', 'nasal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267537, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267538, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267539, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267540, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267541, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004211', 'abnormal sour taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267542, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002161', 'abnormal fertility/fecundity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267543, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267544, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004751', 'increased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267545, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267546, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0013642', 'decreased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267547, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004752', 'decreased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267548, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0000738', 'impaired muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267549, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0030990', 'nerve inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267550, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267551, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267552, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0006003', 'abnormal large intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267553, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267554, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001853', 'heart inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267555, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0011936', 'abnormal PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267556, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0000743', 'muscle spasm', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267557, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267558, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004558', 'delayed allantois development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267559, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0013634', 'increased femur fracture load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267560, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267561, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0009384', 'cardiac valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267562, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0031111', 'meningoencephalitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267563, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267564, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005666', 'abnormal adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267565, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001851', 'eye inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267566, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001629', 'abnormal heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267567, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004145', 'abnormal muscle electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267568, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0031402', 'decreased muscle fatigability', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267569, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267570, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0010071', 'abnormal pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267571, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001983', 'abnormal olfactory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267572, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004010', 'increased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267573, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0031088', 'coughing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267574, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267575, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004009', 'abnormal diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267576, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005410', 'abnormal fertilization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267577, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004782', 'abnormal surfactant physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267578, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0030214', 'muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267579, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267580, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0031241', 'decreased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267581, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267582, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0010505', 'abnormal T wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267583, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003746', 'stomatitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267584, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267585, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0010377', 'abnormal gut flora balance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267586, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0006114', 'cardiac murmur', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267587, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267588, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0010504', 'abnormal RR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267589, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267590, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0010538', 'increased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267591, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0000350', 'abnormal cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267592, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0012111', 'failure of morula compaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267593, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267594, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008004', 'abnormal stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267595, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0031222', 'decreased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267596, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267597, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008691', 'decreased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267598, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020000', 'abnormal response to antigen', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267599, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008713', 'abnormal cytokine level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267600, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267601, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020040', 'decreased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267602, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0000351', 'increased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267603, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0011920', 'abnormal S wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267604, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0009792', 'seborrheic dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267605, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0030924', 'early exit from telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267606, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267607, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0000751', 'myopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267608, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0031051', 'lymph node hemorrhage', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267609, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004994', 'abnormal brain wave pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267610, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002418', 'increased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267611, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267612, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003889', 'enhanced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267613, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267614, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020096', 'high mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267615, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267616, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002330', 'abnormal bronchial provocation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267617, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0012565', 'perivasculitis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267618, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0011952', 'decreased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267619, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001790', 'abnormal immune system physiology', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267620, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0011809', 'abnormal anoikis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267621, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020938', 'decreased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267622, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267623, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267624, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001846', 'increased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267625, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008669', 'increased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267626, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001636', 'irregular heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267627, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020946', 'increased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267628, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0021015', 'increased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267629, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267630, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0011805', 'decreased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267631, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001634', 'internal hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267632, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267633, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008700', 'decreased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267634, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267635, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001850', 'increased susceptibility to otitis media', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267636, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267637, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004143', 'muscle hypertonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267638, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004877', 'abnormal systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267639, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0014275', 'increased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267640, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003079', 'decreased susceptibility to induced joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267641, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0010922', 'alveolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267642, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0031128', 'cardiovascular shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267643, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267644, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003394', 'increased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267645, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267646, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003633', 'abnormal nervous system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267647, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0013459', 'perioral dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267648, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267649, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267650, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001666', 'abnormal intestinal absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267651, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267652, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267653, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004760', 'increased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267654, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267655, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0030130', 'gum inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267656, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002406', 'increased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267657, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267658, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267659, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001914', 'hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267660, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267661, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267662, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0030132', 'periodontium inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267663, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267664, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0011763', 'urethritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267665, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002420', 'abnormal adaptive immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267666, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0031092', 'dysgeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267667, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267668, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0031053', 'pleuritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267669, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004149', 'increased bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267670, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0010680', 'abnormal skin adnexa physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267671, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002578', 'impaired ability to fire action potentials', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267672, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267673, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004780', 'abnormal surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267674, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0012006', 'abnormal hippocampus physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267675, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002472', 'impaired complement alternative pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267676, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002314', 'abnormal respiratory mechanics', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267677, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267678, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003260', 'vomiting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267679, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008666', 'increased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267680, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0000313', 'abnormal cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267681, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0009058', 'decreased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267682, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0012120', 'trophectoderm cell degeneration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267683, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0009247', 'meteorism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267684, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0010381', 'abnormal dosage compensation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267685, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267686, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0010756', 'decreased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267687, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0006002', 'abnormal small intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267688, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020935', 'decreased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267689, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003878', 'abnormal ear physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267690, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0010741', 'abnormal melanocyte proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267691, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267692, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005532', 'abnormal vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267693, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008776', 'increased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267694, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267695, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008751', 'abnormal interleukin level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267696, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0013632', 'increased femur maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267697, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267698, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005025', 'abnormal response to infection', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267699, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0030988', 'dysosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267700, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005364', 'increased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267701, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002498', 'abnormal acute inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267702, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008696', 'increased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267703, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004031', 'insulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267704, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001862', 'interstitial pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267705, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0010552', 'abnormal HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267706, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003621', 'dysuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267707, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002471', 'abnormal complement pathway', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267708, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267709, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267710, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267711, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003412', 'abnormal afterhyperpolarization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267712, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267713, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003899', 'abnormal QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267714, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020947', 'decreased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267715, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0012554', 'increased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267716, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003925', 'abnormal cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267717, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267718, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002896', 'abnormal bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267719, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0010073', 'decreased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267720, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004510', 'myositis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267721, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267722, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008555', 'abnormal interferon secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267723, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267724, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267725, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267726, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002128', 'abnormal blood circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267727, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001951', 'abnormal breathing pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267728, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004945', 'abnormal bone resorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267729, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0009643', 'abnormal urine homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267730, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267731, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005501', 'abnormal skin physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267732, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008708', 'increased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267733, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267734, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267735, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001648', 'abnormal apoptosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267736, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267737, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008566', 'increased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267738, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003823', 'increased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267739, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267740, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267741, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267742, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0000304', 'abnormal cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267743, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005403', 'abnormal nerve conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267744, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004512', 'anosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267745, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267746, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008003', 'achlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267747, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267748, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008697', 'decreased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267749, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0030153', 'dental pulp inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267750, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0031169', 'abnormal joint physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267751, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267752, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008567', 'decreased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267753, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003762', 'abnormal immune organ physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267754, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001633', 'poor circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267755, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267756, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0010211', 'abnormal acute phase protein level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267757, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267758, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267759, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0009062', 'impaired lectin complement pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267760, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002419', 'abnormal innate immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267761, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005076', 'abnormal cell differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267762, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001858', 'intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267763, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267764, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267765, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0011951', 'increased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267766, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008672', 'increased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267767, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001800', 'abnormal humoral immune response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267768, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267769, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0031129', 'left-to-right shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267770, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267771, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267772, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267773, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003866', 'abnormal defecation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267774, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267775, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267776, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267777, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003699', 'abnormal female reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267778, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267779, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008673', 'decreased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267780, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267781, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0011717', 'increased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267782, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002296', 'aspiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267783, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0013555', 'abnormal apocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267784, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0006001', 'abnormal intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267785, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267786, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0011804', 'increased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267787, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0031104', 'crackles', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267788, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0011045', 'decreased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267789, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008568', 'abnormal interleukin secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267790, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0013475', 'delayed reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267791, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020944', 'decreased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267792, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267793, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267794, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003880', 'abnormal central pattern generator function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267795, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008705', 'increased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267796, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008748', 'abnormal central T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267797, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005580', 'periinsulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267798, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267799, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267800, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008699', 'increased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267801, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267802, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008563', 'decreased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267803, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020949', 'increased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267804, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003259', 'nausea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267805, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020155', 'enhanced humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267806, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003777', 'lip inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267807, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267808, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003123', 'paternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267809, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267810, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005036', 'diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267811, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002998', 'abnormal bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267812, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267813, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267814, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003726', 'decreased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267815, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020934', 'increased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267816, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267817, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003298', 'choking', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267818, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267819, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267820, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267821, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0000503', 'excessive digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267822, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008747', 'abnormal T cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267823, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267824, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001985', 'abnormal gustatory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267825, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008565', 'decreased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267826, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001873', 'stomach inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267827, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267828, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267829, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0011432', 'decreased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267830, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267831, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0012556', 'increased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267832, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003157', 'impaired muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267833, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267834, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0009732', 'ventricular premature beat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267835, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002405', 'respiratory system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267836, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0021016', 'decreased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267837, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020039', 'increased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267838, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267839, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0011013', 'bronchiolectasis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267840, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0030987', 'spinal cord inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267841, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267842, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0011012', 'bronchiectasis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267843, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002133', 'abnormal respiratory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267844, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0031014', 'polyspermy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267845, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004947', 'skin inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267846, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0031013', 'abnormal egg activation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267847, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003725', 'increased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267848, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003927', 'increased cellular glucose import', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267849, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267850, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020002', 'increased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267851, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0030129', 'tongue inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267852, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003820', 'increased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267853, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003477', 'abnormal nerve fiber response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267854, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002634', 'abnormal sensorimotor gating', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267855, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267856, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0012608', 'abnormal complement C5 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267857, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005043', 'defective assembly of class II molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267858, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267859, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001663', 'abnormal digestive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267860, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0031425', 'enhanced male fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267861, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001876', 'decreased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267862, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267863, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008676', 'decreased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267864, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0030909', 'abnormal melanocyte adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267865, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003122', 'maternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267866, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267867, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267868, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267869, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020846', 'abnormal cell motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267870, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003091', 'abnormal cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267871, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267872, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267873, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003926', 'decreased cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267874, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002635', 'reduced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267875, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0000740', 'impaired smooth muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267876, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003393', 'decreased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267877, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008706', 'decreased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267878, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008006', 'increased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267879, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267880, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005613', 'increased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267881, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0011048', 'decreased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267882, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008002', 'hyperchlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267883, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0012553', 'decreased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267884, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267885, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0011431', 'increased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267886, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008652', 'decreased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267887, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004761', 'increased susceptibility to induced pancreatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267888, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267889, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0031066', 'cytokine storm', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267890, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267891, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008544', 'impaired olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267892, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267893, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267894, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267895, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267896, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0010143', 'enhanced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267897, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0010758', 'increased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267898, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0031242', 'increased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267899, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0013644', 'increased vertebra maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267900, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0010560', 'intraventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267901, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004213', 'abnormal umami taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267902, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008942', 'abnormal induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267903, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008651', 'increased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267904, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0000427', 'abnormal hair cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267905, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003767', 'palate inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267906, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020386', 'adipose tissue inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267907, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267908, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0013641', 'increased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267909, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002421', 'abnormal cell-mediated immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267910, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001984', 'abnormal olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267911, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0031086', 'wheezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267912, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0013498', 'trachea inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267913, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002693', 'abnormal pancreas physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267914, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0031102', 'rhinorrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267915, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0013638', 'decreased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267916, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003467', 'abnormal single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267917, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003292', 'melena', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267918, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0010072', 'increased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267919, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008681', 'increased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267920, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267921, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267922, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267923, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005001', 'abnormal clonal deletion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267924, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267925, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002254', 'reproductive system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267926, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008678', 'increased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267927, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003077', 'abnormal cell cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267928, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267929, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008943', 'increased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267930, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267931, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020925', 'increased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267932, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267933, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008558', 'abnormal interferon-beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267934, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0014030', 'abnormal mucous gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267935, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008693', 'increased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267936, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267937, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0010950', 'abnormal lung hysteresivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267938, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008564', 'increased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267939, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001819', 'abnormal immune cell physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267940, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0011046', 'abnormal lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267941, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020142', 'increased anti-sperm antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267942, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008660', 'increased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267943, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002473', 'impaired complement classical pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267944, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001872', 'sinus inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267945, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267946, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001793', 'abnormal susceptibility to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267947, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020412', 'abnormal amnion physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267948, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267949, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008687', 'increased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267950, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003463', 'abnormal single cell response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267951, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008260', 'abnormal autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267952, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0031054', 'bronchiolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267953, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267954, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267955, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267956, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267957, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002409', 'decreased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267958, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0011994', 'increased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267959, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0030215', 'facial muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267960, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0014274', 'decreased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267961, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267962, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0013640', 'increased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267963, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0013637', 'increased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267964, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0010695', 'abnormal blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267965, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0031469', 'abnormal pinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267966, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267967, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004212', 'abnormal salty taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267968, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008861', 'abnormal hair shedding', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267969, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005620', 'abnormal muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267970, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0011082', 'abnormal gastrointestinal motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267971, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267972, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267973, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002338', 'abnormal pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267974, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001933', 'abnormal litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267975, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267976, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008752', 'abnormal tumor necrosis factor level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267977, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267978, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005671', 'abnormal response to transplant', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267979, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020001', 'decreased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267980, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0011918', 'abnormal PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267981, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267982, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001756', 'abnormal urination', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267983, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0031130', 'right-to-left shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267984, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267985, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0011919', 'abnormal R wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267986, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0013136', 'genital discharge', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267987, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267988, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267989, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002841', 'impaired skeletal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267990, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0031091', 'hypogeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267991, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267992, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002064', 'seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267993, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0030822', 'sacroiliac joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267994, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005088', 'increased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267995, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003875', 'abnormal hair follicle regression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267996, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267997, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008664', 'decreased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(267998, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0012382', 'abnormal blood cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(267999, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0013625', 'increased femur yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268000, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268001, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268002, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268003, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0006082', 'CNS inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268004, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0009057', 'increased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268005, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008663', 'increased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268006, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268007, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268008, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008690', 'increased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268009, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268010, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001945', 'bronchoconstriction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268011, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003116', 'rickets', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268012, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0011194', 'abnormal hair follicle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268013, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268014, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008685', 'decreased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268015, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268016, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008712', 'decreased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268017, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268018, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001627', 'abnormal cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268019, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268020, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004072', 'abnormal frontal plane axis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268021, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002499', 'chronic inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268022, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0009046', 'muscle twitch', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268023, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268024, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0013971', 'blood in lymph vessels', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268025, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003464', 'abnormal single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268026, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0031221', 'abnormal CXCL10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268027, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0010155', 'abnormal intestine physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268028, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0013627', 'increased vertebra yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268029, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0031170', 'abnormal vasculature physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268030, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001841', 'decreased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268031, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003303', 'peritoneal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268032, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268033, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003261', 'hematemesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268034, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005333', 'decreased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268035, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0031095', 'pharyngitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268036, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0013559', 'abnormal exocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268037, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005621', 'abnormal cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268038, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003659', 'abnormal lymph circulation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268039, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001194', 'dermatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268040, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002106', 'abnormal muscle physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268041, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0011925', 'abnormal heart echocardiography feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268042, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008817', 'hematoma', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268043, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268044, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008675', 'increased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268045, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268046, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003278', 'esophageal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268047, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001844', 'autoimmune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268048, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0009697', 'abnormal copulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268049, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268050, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0012197', 'impaired myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268051, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0011518', 'abnormal cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268052, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0010954', 'abnormal cellular respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268053, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0009562', 'abnormal odor adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268054, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268055, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0011764', 'ureteritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268056, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004036', 'abnormal muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268057, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001921', 'reduced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268058, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004759', 'decreased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268059, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268060, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0031089', 'sneezing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268061, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008722', 'abnormal chemokine secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268062, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002993', 'arthritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268063, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020845', 'abnormal DNA-templated transcription', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268064, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001847', 'brain inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268065, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268066, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0010822', 'pneumothorax', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268067, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268068, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0013806', 'encephalopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268069, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0031224', 'abnormal CXCL10 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268070, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001542', 'abnormal bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268071, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008744', 'abnormal B cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268072, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005044', 'sepsis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268073, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004085', 'abnormal heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268074, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005087', 'decreased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268075, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0006138', 'congestive heart failure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268076, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0013557', 'abnormal merocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268077, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268078, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020953', 'decreased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268079, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001840', 'increased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268080, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268081, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268082, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020952', 'increased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268083, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0010994', 'aerophagia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268084, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008684', 'increased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268085, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003882', 'abnormal pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268086, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268087, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020950', 'decreased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268088, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268089, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268090, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268091, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020154', 'impaired humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268092, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0031009', 'abnormal sperm-egg fusion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268093, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0012555', 'decreased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268094, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001664', 'abnormal digestion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268095, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268096, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008711', 'increased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268097, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003566', 'abnormal cell adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268098, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0031090', 'ageusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268099, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0006080', 'brain ischemia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268100, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020926', 'decreased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268101, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008775', 'abnormal heart ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268102, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003698', 'abnormal male reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268103, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268104, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0010753', 'improved mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268105, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020147', 'abnormal defecation amount', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268106, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0031105', 'rhonchi', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268107, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268108, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001837', 'defective assembly of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268109, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008814', 'decreased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268110, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020941', 'decreased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268111, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268112, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268113, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020937', 'increased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268114, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268115, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004122', 'abnormal sinus arrhythmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268116, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0030951', 'abnormal endocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268117, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268118, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268119, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003471', 'abnormal summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268120, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0011927', 'abnormal cardiac valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268121, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001943', 'abnormal respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268122, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0009045', 'muscle tetany', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268123, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001861', 'lung inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268124, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003674', 'oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268125, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020138', 'delayed bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268126, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0011566', 'abnormal complement protein level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268127, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268128, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008682', 'decreased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268129, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008272', 'abnormal endochondral bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268130, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0000352', 'decreased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268131, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268132, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0011043', 'abnormal lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268133, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0000501', 'abnormal digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268134, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020848', 'abnormal exocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268135, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0010539', 'decreased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268136, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002694', 'abnormal pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268137, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268138, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0012685', 'abnormal primitive streak elongation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268139, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004046', 'abnormal mitosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268140, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268141, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0031126', 'gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268142, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002322', 'abnormal respiratory transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268143, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001963', 'abnormal hearing physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268144, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0013636', 'abnormal bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268145, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001533', 'abnormal skeleton physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268146, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002333', 'abnormal lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268147, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004037', 'increased muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268148, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0013942', 'enthesitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268149, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001950', 'abnormal respiratory sounds', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268150, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268151, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003186', 'abnormal redox activity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268152, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003868', 'abnormal feces composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268153, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268154, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005000', 'abnormal immune tolerance', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268155, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008271', 'abnormal bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268156, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004484', 'abnormal response of heart to induced stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268157, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003547', 'abnormal pulmonary pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268158, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002842', 'increased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268159, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268160, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268161, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0010559', 'heart block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268162, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0031055', 'bronchitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268163, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0011718', 'decreased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268164, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003474', 'abnormal summary potential intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268165, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268166, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008721', 'abnormal chemokine level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268167, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020381', 'muscle gating pore current', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268168, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268169, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001867', 'rhinitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268170, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020097', 'low mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268171, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008562', 'increased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268172, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268173, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268174, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008688', 'decreased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268175, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268176, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001835', 'abnormal antigen presentation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268177, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268178, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004142', 'abnormal muscle tone', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268179, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0031306', 'abnormal cartilage physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268180, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268181, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268182, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008661', 'decreased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268183, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0031098', 'abnormal sputum production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268184, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001947', 'abnormal mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268185, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268186, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0013561', 'abnormal endocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268187, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0031223', 'increased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268188, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005645', 'abnormal hypothalamus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268189, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008702', 'increased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268190, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0031110', 'meningitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268191, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268192, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268193, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001598', 'abnormal blood viscosity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268194, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003898', 'abnormal QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268195, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268196, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0014037', 'stranguria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268197, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268198, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003787', 'abnormal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268199, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0013752', 'stridor', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268200, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001924', 'infertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268201, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268202, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268203, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268204, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001864', 'vascular inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268205, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003824', 'decreased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268206, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020940', 'increased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268207, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0011047', 'increased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268208, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0031424', 'enhanced female fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268209, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268210, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003865', 'lymph node inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268211, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268212, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268213, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003470', 'abnormal summary potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268214, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0013134', 'poor circulation in autopods', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268215, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0030216', 'tongue muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268216, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268217, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0009567', 'mitotic nondisjunction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268218, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0011044', 'increased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268219, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008007', 'abnormal cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268220, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268221, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003009', 'abnormal cytokine secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268222, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0031240', 'abnormal CSF3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268223, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0031302', 'syncope', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268224, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0011926', 'abnormal heart valve physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268225, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0010752', 'impaired mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268226, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008737', 'abnormal spleen physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268227, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002723', 'abnormal immune serum protein physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268228, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268229, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004781', 'abnormal surfactant composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268230, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002933', 'joint inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268231, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268232, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004796', 'increased anti-histone antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268233, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268234, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0013639', 'decreased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268235, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005190', 'osteomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268236, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0011762', 'renal/urinary system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268237, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268238, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0011399', 'increased endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268239, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008005', 'decreased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268240, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020943', 'increased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268241, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0009473', 'abnormal skin exfoliation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268242, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020371', 'abnormal glymphatic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268243, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002327', 'abnormal respiratory function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268244, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008001', 'hypochlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268245, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268246, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001845', 'abnormal inflammatory response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268247, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001761', 'abnormal urination pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268248, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002500', 'granulomatous inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268249, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268250, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002164', 'abnormal gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268251, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268252, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008750', 'abnormal interferon level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268253, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0000343', 'abnormal response to cardiac infarction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268254, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268255, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005402', 'abnormal action potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268256, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0000505', 'decreased digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268257, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268258, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268259, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268260, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005253', 'abnormal eye physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268261, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268262, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268263, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005005', 'abnormal self tolerance', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268264, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001869', 'pancreas inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268265, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0013135', 'poor circulation in tail', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268266, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0000316', 'cellular necrosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268267, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0013556', 'abnormal holocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268268, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003280', 'urinary incontinence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268269, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268270, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0001849', 'ear inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268271, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005275', 'abnormal skin tensile strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268272, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0030991', 'optic nerve inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268273, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0004011', 'decreased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268274, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0031246', 'abnormal CCL3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268275, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0000423', 'delayed hair regrowth', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268276, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003454', 'erythroderma', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268277, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268278, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0031125', 'aspiration pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268279, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(268280, 'HP:0034063', 'Anti-islet antigen-2 antibody positivity', 'MP:0003897', 'abnormal ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(268281, 'HP:0031260', 'Triangular tibia', 'MP:0030823', 'increased femur size', 0.4264705882352941, 7.694257931681313, 1.8114565151165531, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(268282, 'HP:0031260', 'Triangular tibia', 'MP:0000482', 'long fibula', 0.4305555555555556, 10.757481540995707, 2.152136947608595, 'UPHENO:0086780', 'abnormal hindlimb zeugopod morphology'),
(268283, 'HP:0031260', 'Triangular tibia', 'MP:0004358', 'bowed tibia', 0.4177215189873418, 12.548253578857707, 2.289470581946575, 'UPHENO:0020975', 'abnormal tibia morphology'),
(268284, 'HP:0031260', 'Triangular tibia', 'MP:0030825', 'decreased femur size', 0.4264705882352941, 7.694257931681313, 1.8114565151165531, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(268285, 'HP:0031260', 'Triangular tibia', 'MP:0000558', 'abnormal tibia morphology', 0.4166666666666667, 12.33412877350486, 2.266984852682896, 'UPHENO:0087561', 'abnormal tibia morphology'),
(268286, 'HP:0031260', 'Triangular tibia', 'MP:0002765', 'short fibula', 0.4305555555555556, 10.757481540995707, 2.152136947608595, 'UPHENO:0086780', 'abnormal hindlimb zeugopod morphology'),
(268287, 'HP:0031260', 'Triangular tibia', 'MP:0008152', 'decreased diameter of femur', 0.4142857142857143, 7.694257931681313, 1.7853910336744485, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(268288, 'HP:0031260', 'Triangular tibia', 'MP:0008162', 'increased diameter of tibia', 0.4032258064516129, 12.33412877350486, 2.2301208535804826, 'UPHENO:0087561', 'abnormal tibia morphology'),
(268289, 'HP:0031260', 'Triangular tibia', 'MP:0008158', 'increased diameter of femur', 0.4142857142857143, 7.694257931681313, 1.7853910336744485, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(268290, 'HP:0031260', 'Triangular tibia', 'MP:0008156', 'decreased diameter of tibia', 0.4032258064516129, 12.33412877350486, 2.2301208535804826, 'UPHENO:0087561', 'abnormal tibia morphology'),
(268291, 'HP:0031260', 'Triangular tibia', 'MP:0030827', 'femur fracture', 0.43283582089552236, 7.694257931681313, 1.8249247787350484, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(268292, 'HP:0031260', 'Triangular tibia', 'MP:0002764', 'short tibia', 0.4714285714285714, 12.548253578857707, 2.432201730655652, 'UPHENO:0020975', 'abnormal tibia morphology'),
(268293, 'HP:0031260', 'Triangular tibia', 'MP:0004357', 'long tibia', 0.4714285714285714, 12.548253578857707, 2.432201730655652, 'UPHENO:0020975', 'abnormal tibia morphology'),
(268294, 'HP:4000138', 'Absent cavum septum pellucidum', 'MP:0012137', 'abnormal forebrain size', 0.425531914893617, 9.371930806217245, 1.997011683045471, 'UPHENO:0020888', 'abnormal forebrain morphology'),
(268295, 'HP:0033934', 'Arcuate vein intimal/medial storage material accumulation', 'MP:0011382', 'abnormal kidney lobule morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(268296, 'HP:0033934', 'Arcuate vein intimal/medial storage material accumulation', 'MP:0011534', 'granular kidney', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(268297, 'HP:0033934', 'Arcuate vein intimal/medial storage material accumulation', 'MP:0012024', 'abnormal nephron morphogenesis', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(268298, 'HP:0033934', 'Arcuate vein intimal/medial storage material accumulation', 'MP:0004195', 'abnormal kidney calyx morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(268299, 'HP:0033934', 'Arcuate vein intimal/medial storage material accumulation', 'MP:0004192', 'abnormal kidney pyramid morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(268300, 'HP:0033934', 'Arcuate vein intimal/medial storage material accumulation', 'MP:0002135', 'abnormal kidney morphology', 0.46875, 7.667568053596582, 1.8958302996638168, 'UPHENO:0076779', 'abnormal kidney morphology'),
(268301, 'HP:0033934', 'Arcuate vein intimal/medial storage material accumulation', 'MP:0011332', 'abnormal kidney outer medulla morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(268302, 'HP:0033934', 'Arcuate vein intimal/medial storage material accumulation', 'MP:0009860', 'nephrosclerosis', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(268303, 'HP:0033934', 'Arcuate vein intimal/medial storage material accumulation', 'MP:0011364', 'abnormal metanephros morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(268304, 'HP:0033934', 'Arcuate vein intimal/medial storage material accumulation', 'MP:0002829', 'abnormal juxtaglomerular apparatus morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(268305, 'HP:0033934', 'Arcuate vein intimal/medial storage material accumulation', 'MP:0003613', 'abnormal kidney medulla development', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(268306, 'HP:0033934', 'Arcuate vein intimal/medial storage material accumulation', 'MP:0004969', 'pale kidney', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(268307, 'HP:0033934', 'Arcuate vein intimal/medial storage material accumulation', 'MP:0003014', 'abnormal kidney medulla morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(268308, 'HP:0033934', 'Arcuate vein intimal/medial storage material accumulation', 'MP:0000521', 'abnormal kidney cortex morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(268309, 'HP:0033934', 'Arcuate vein intimal/medial storage material accumulation', 'MP:0000527', 'abnormal kidney development', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(268310, 'HP:0033934', 'Arcuate vein intimal/medial storage material accumulation', 'MP:0011376', 'abnormal kidney corticomedullary boundary morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(268311, 'HP:0033934', 'Arcuate vein intimal/medial storage material accumulation', 'MP:0011425', 'abnormal kidney interstitium morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(268312, 'HP:0033934', 'Arcuate vein intimal/medial storage material accumulation', 'MP:0011347', 'abnormal kidney medullary ray morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(268313, 'HP:0033934', 'Arcuate vein intimal/medial storage material accumulation', 'MP:0011381', 'abnormal kidney lobe morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(268314, 'HP:0033934', 'Arcuate vein intimal/medial storage material accumulation', 'MP:0004967', 'abnormal kidney epithelium morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(268315, 'HP:0033934', 'Arcuate vein intimal/medial storage material accumulation', 'MP:0011383', 'abnormal kidney capsule morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(268316, 'HP:0033934', 'Arcuate vein intimal/medial storage material accumulation', 'MP:0011402', 'renal cast', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(268317, 'HP:0033934', 'Arcuate vein intimal/medial storage material accumulation', 'MP:0003881', 'abnormal nephron morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(268318, 'HP:0033934', 'Arcuate vein intimal/medial storage material accumulation', 'MP:0011333', 'abnormal kidney inner medulla morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(268319, 'HP:0033934', 'Arcuate vein intimal/medial storage material accumulation', 'MP:0004194', 'abnormal kidney pelvis morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(268320, 'HP:0031033', 'Impaired urinary acidification', 'MP:0011442', 'abnormal renal sodium ion transport', 0.5151515151515151, 10.834557764014349, 2.3625068990647633, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268321, 'HP:0031033', 'Impaired urinary acidification', 'MP:0011371', 'decreased kidney apoptosis', 0.4146341463414634, 10.834557764014349, 2.119522967431437, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268322, 'HP:0031033', 'Impaired urinary acidification', 'MP:0021053', 'abnormal renal arterial blood pressure', 0.4473684210526316, 10.834557764014349, 2.201599191426684, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268323, 'HP:0031033', 'Impaired urinary acidification', 'MP:0011437', 'glomerulus hemorrhage', 0.425, 10.834557764014349, 2.145853454853359, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268324, 'HP:0031033', 'Impaired urinary acidification', 'MP:0003621', 'dysuria', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(268325, 'HP:0031033', 'Impaired urinary acidification', 'MP:0004051', 'increased renal sympathetic nerve activity', 0.5151515151515151, 10.834557764014349, 2.3625068990647633, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268326, 'HP:0031033', 'Impaired urinary acidification', 'MP:0002987', 'abnormal urine osmolality', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(268327, 'HP:0031033', 'Impaired urinary acidification', 'MP:0011447', 'abnormal renal glucose reabsorption', 0.4722222222222222, 10.834557764014349, 2.261928147425971, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268328, 'HP:0031033', 'Impaired urinary acidification', 'MP:0011900', 'podocyturia', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(268329, 'HP:0031033', 'Impaired urinary acidification', 'MP:0011444', 'abnormal renal water homeostasis', 0.53125, 10.834557764014349, 2.3991370974024435, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268330, 'HP:0031033', 'Impaired urinary acidification', 'MP:0031482', 'abnormal urine hypoxanthine level', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(268331, 'HP:0031033', 'Impaired urinary acidification', 'MP:0002136', 'abnormal kidney physiology', 0.5483870967741935, 10.834557764014349, 2.43752572848783, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268332, 'HP:0031033', 'Impaired urinary acidification', 'MP:0011367', 'abnormal kidney apoptosis', 0.4473684210526316, 10.834557764014349, 2.201599191426684, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268333, 'HP:0031033', 'Impaired urinary acidification', 'MP:0011465', 'abnormal urine urea nitrogen level', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(268334, 'HP:0031033', 'Impaired urinary acidification', 'MP:0000327', 'hemosiderinuria', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(268335, 'HP:0031033', 'Impaired urinary acidification', 'MP:0021055', 'decreased renal arterial blood pressure', 0.425, 10.834557764014349, 2.145853454853359, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268336, 'HP:0031033', 'Impaired urinary acidification', 'MP:0013284', 'abnormal renal glomerular filtration', 0.5151515151515151, 10.834557764014349, 2.3625068990647633, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268337, 'HP:0031033', 'Impaired urinary acidification', 'MP:0031404', 'increased tubuloglomerular feedback response', 0.5151515151515151, 10.834557764014349, 2.3625068990647633, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268338, 'HP:0031033', 'Impaired urinary acidification', 'MP:0010109', 'abnormal renal sodium reabsorption', 0.4358974358974359, 10.834557764014349, 2.1731902697224905, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268339, 'HP:0031033', 'Impaired urinary acidification', 'MP:0002708', 'nephrolithiasis', 0.4473684210526316, 10.834557764014349, 2.201599191426684, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268340, 'HP:0031033', 'Impaired urinary acidification', 'MP:0001859', 'kidney inflammation', 0.4358974358974359, 10.834557764014349, 2.1731902697224905, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268341, 'HP:0031033', 'Impaired urinary acidification', 'MP:0011441', 'decreased kidney cell proliferation', 0.4358974358974359, 10.834557764014349, 2.1731902697224905, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268342, 'HP:0031033', 'Impaired urinary acidification', 'MP:0011445', 'abnormal renal protein reabsorption', 0.4473684210526316, 10.834557764014349, 2.201599191426684, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268343, 'HP:0031033', 'Impaired urinary acidification', 'MP:0021054', 'increased renal arterial blood pressure', 0.425, 10.834557764014349, 2.145853454853359, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268344, 'HP:0031033', 'Impaired urinary acidification', 'MP:0001761', 'abnormal urination pattern', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(268345, 'HP:0031033', 'Impaired urinary acidification', 'MP:0010108', 'abnormal renal water reabsorption', 0.4358974358974359, 10.834557764014349, 2.1731902697224905, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268346, 'HP:0031033', 'Impaired urinary acidification', 'MP:0009348', 'abnormal urine pH', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(268347, 'HP:0031033', 'Impaired urinary acidification', 'MP:0011372', 'decreased renal tubule apoptosis', 0.40476190476190477, 10.834557764014349, 2.0941385431282553, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268348, 'HP:0031033', 'Impaired urinary acidification', 'MP:0011370', 'increased mesangial cell apoptosis', 0.40476190476190477, 10.834557764014349, 2.0941385431282553, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268349, 'HP:0031033', 'Impaired urinary acidification', 'MP:0031480', 'abnormal urine xanthine level', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(268350, 'HP:0031033', 'Impaired urinary acidification', 'MP:0011418', 'leukocyturia', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(268351, 'HP:0031033', 'Impaired urinary acidification', 'MP:0001948', 'vesicoureteral reflux', 0.53125, 10.834557764014349, 2.3991370974024435, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268352, 'HP:0031033', 'Impaired urinary acidification', 'MP:0013285', 'abnormal renal filtration', 0.53125, 10.834557764014349, 2.3991370974024435, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268353, 'HP:0031033', 'Impaired urinary acidification', 'MP:0011440', 'increased kidney cell proliferation', 0.4358974358974359, 10.834557764014349, 2.1731902697224905, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268354, 'HP:0031033', 'Impaired urinary acidification', 'MP:0010386', 'abnormal urinary bladder physiology', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(268355, 'HP:0031033', 'Impaired urinary acidification', 'MP:0003280', 'urinary incontinence', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(268356, 'HP:0031033', 'Impaired urinary acidification', 'MP:0011431', 'increased urine flow rate', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(268357, 'HP:0031033', 'Impaired urinary acidification', 'MP:0011758', 'renal ischemia', 0.53125, 10.834557764014349, 2.3991370974024435, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268358, 'HP:0031033', 'Impaired urinary acidification', 'MP:0005557', 'increased creatinine clearance', 0.4358974358974359, 10.834557764014349, 2.1731902697224905, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268359, 'HP:0031033', 'Impaired urinary acidification', 'MP:0013305', 'isosthenuria', 0.53125, 10.834557764014349, 2.3991370974024435, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268360, 'HP:0031033', 'Impaired urinary acidification', 'MP:0010107', 'abnormal renal reabsorption', 0.53125, 10.834557764014349, 2.3991370974024435, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268361, 'HP:0031033', 'Impaired urinary acidification', 'MP:0011368', 'increased kidney apoptosis', 0.4146341463414634, 10.834557764014349, 2.119522967431437, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268362, 'HP:0031033', 'Impaired urinary acidification', 'MP:0011439', 'abnormal kidney cell proliferation', 0.4594594594594595, 10.834557764014349, 2.231152180765876, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268363, 'HP:0031033', 'Impaired urinary acidification', 'MP:0011446', 'abnormal renal albumin reabsorption', 0.4358974358974359, 10.834557764014349, 2.1731902697224905, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268364, 'HP:0031033', 'Impaired urinary acidification', 'MP:0002847', 'abnormal renal glomerular filtration rate', 0.40476190476190477, 10.834557764014349, 2.0941385431282553, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268365, 'HP:0031033', 'Impaired urinary acidification', 'MP:0011375', 'decreased renal glomerulus apoptosis', 0.40476190476190477, 10.834557764014349, 2.0941385431282553, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268366, 'HP:0031033', 'Impaired urinary acidification', 'MP:0012576', 'abnormal kidney glutathione peroxidase activity', 0.4594594594594595, 10.834557764014349, 2.231152180765876, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268367, 'HP:0031033', 'Impaired urinary acidification', 'MP:0004050', 'abnormal renal sympathetic nerve activity', 0.53125, 10.834557764014349, 2.3991370974024435, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268368, 'HP:0031033', 'Impaired urinary acidification', 'MP:0011373', 'decreased mesangial cell apoptosis', 0.40476190476190477, 10.834557764014349, 2.0941385431282553, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268369, 'HP:0031033', 'Impaired urinary acidification', 'MP:0011405', 'tubulointerstitial nephritis', 0.425, 10.834557764014349, 2.145853454853359, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268370, 'HP:0031033', 'Impaired urinary acidification', 'MP:0011297', 'absent tubuloglomerular feedback response', 0.5151515151515151, 10.834557764014349, 2.3625068990647633, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268371, 'HP:0031033', 'Impaired urinary acidification', 'MP:0004041', 'increased susceptibility to kidney reperfusion injury', 0.4857142857142857, 10.834557764014349, 2.294013837224701, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268372, 'HP:0031033', 'Impaired urinary acidification', 'MP:0004052', 'decreased renal sympathetic nerve activity', 0.5151515151515151, 10.834557764014349, 2.3625068990647633, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268373, 'HP:0031033', 'Impaired urinary acidification', 'MP:0011296', 'decreased tubuloglomerular feedback response', 0.5151515151515151, 10.834557764014349, 2.3625068990647633, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268374, 'HP:0031033', 'Impaired urinary acidification', 'MP:0011295', 'abnormal tubuloglomerular feedback response', 0.53125, 10.834557764014349, 2.3991370974024435, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268375, 'HP:0031033', 'Impaired urinary acidification', 'MP:0004153', 'increased renal tubule apoptosis', 0.40476190476190477, 10.834557764014349, 2.0941385431282553, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268376, 'HP:0031033', 'Impaired urinary acidification', 'MP:0010028', 'aciduria', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(268377, 'HP:0031033', 'Impaired urinary acidification', 'MP:0003606', 'kidney failure', 0.5, 10.834557764014349, 2.3275048618654215, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268378, 'HP:0031033', 'Impaired urinary acidification', 'MP:0005531', 'increased renal vascular resistance', 0.4358974358974359, 10.834557764014349, 2.1731902697224905, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268379, 'HP:0031033', 'Impaired urinary acidification', 'MP:0003589', 'abnormal ureter physiology', 0.4411764705882353, 8.666588959537362, 1.955375955975643, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(268380, 'HP:0031033', 'Impaired urinary acidification', 'MP:0000525', 'renal tubular acidosis', 0.4594594594594595, 10.834557764014349, 2.231152180765876, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268381, 'HP:0031033', 'Impaired urinary acidification', 'MP:0000533', 'kidney hemorrhage', 0.4358974358974359, 10.834557764014349, 2.1731902697224905, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268382, 'HP:0031033', 'Impaired urinary acidification', 'MP:0014037', 'stranguria', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(268383, 'HP:0031033', 'Impaired urinary acidification', 'MP:0011443', 'abnormal renal water transport', 0.5, 10.834557764014349, 2.3275048618654215, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268384, 'HP:0031033', 'Impaired urinary acidification', 'MP:0005556', 'abnormal renal filtration rate', 0.4473684210526316, 10.834557764014349, 2.201599191426684, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268385, 'HP:0031033', 'Impaired urinary acidification', 'MP:0009643', 'abnormal urine homeostasis', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(268386, 'HP:0031033', 'Impaired urinary acidification', 'MP:0011417', 'abnormal renal transport', 0.53125, 10.834557764014349, 2.3991370974024435, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268387, 'HP:0031033', 'Impaired urinary acidification', 'MP:0011432', 'decreased urine flow rate', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(268388, 'HP:0031033', 'Impaired urinary acidification', 'MP:0011421', 'cylindruria', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(268389, 'HP:0031033', 'Impaired urinary acidification', 'MP:0011856', 'abnormal glomerular filtration barrier function', 0.5, 10.834557764014349, 2.3275048618654215, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268390, 'HP:0031033', 'Impaired urinary acidification', 'MP:0004042', 'decreased susceptibility to kidney reperfusion injury', 0.4722222222222222, 10.834557764014349, 2.261928147425971, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268391, 'HP:0031033', 'Impaired urinary acidification', 'MP:0004040', 'abnormal susceptibility to kidney reperfusion injury', 0.5, 10.834557764014349, 2.3275048618654215, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268392, 'HP:0031033', 'Impaired urinary acidification', 'MP:0009645', 'crystalluria', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(268393, 'HP:0031033', 'Impaired urinary acidification', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.4666666666666667, 8.666588959537362, 2.011071401297685, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(268394, 'HP:0031033', 'Impaired urinary acidification', 'MP:0011404', 'pyelitis', 0.425, 10.834557764014349, 2.145853454853359, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268395, 'HP:0031033', 'Impaired urinary acidification', 'MP:0005530', 'decreased renal vascular resistance', 0.4358974358974359, 10.834557764014349, 2.1731902697224905, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268396, 'HP:0031033', 'Impaired urinary acidification', 'MP:0001756', 'abnormal urination', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(268397, 'HP:0031033', 'Impaired urinary acidification', 'MP:0010111', 'abnormal renal calcium reabsorption', 0.4594594594594595, 10.834557764014349, 2.231152180765876, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268398, 'HP:0031033', 'Impaired urinary acidification', 'MP:0011403', 'pyelonephritis', 0.425, 10.834557764014349, 2.145853454853359, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268399, 'HP:0031033', 'Impaired urinary acidification', 'MP:0010110', 'abnormal renal phosphate reabsorption', 0.4722222222222222, 10.834557764014349, 2.261928147425971, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268400, 'HP:0031033', 'Impaired urinary acidification', 'MP:0011369', 'increased renal glomerulus apoptosis', 0.40476190476190477, 10.834557764014349, 2.0941385431282553, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268401, 'HP:0031033', 'Impaired urinary acidification', 'MP:0011420', 'pyuria', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(268402, 'HP:0031033', 'Impaired urinary acidification', 'MP:0005529', 'abnormal renal vascular resistance', 0.4473684210526316, 10.834557764014349, 2.201599191426684, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268403, 'HP:0031033', 'Impaired urinary acidification', 'MP:0005558', 'decreased creatinine clearance', 0.4358974358974359, 10.834557764014349, 2.1731902697224905, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(268404, 'HP:0100808', 'Gastric diverticulum', 'MP:0003294', 'intussusception', 0.4375, 8.258419113680198, 1.9008046617775027, 'UPHENO:0076735', 'abnormal alimentary part of gastrointestinal system morphology'),
(268405, 'HP:0100808', 'Gastric diverticulum', 'MP:0000478', 'delayed intestine development', 0.4117647058823529, 8.258419113680198, 1.8440513868647284, 'UPHENO:0076735', 'abnormal alimentary part of gastrointestinal system morphology'),
(268406, 'HP:0100808', 'Gastric diverticulum', 'MP:0000471', 'abnormal stomach epithelium morphology', 0.42105263157894735, 10.592196926445304, 2.111840995454495, 'UPHENO:0081609', 'abnormal stomach morphology'),
(268407, 'HP:0100808', 'Gastric diverticulum', 'MP:0000511', 'abnormal intestinal mucosa morphology', 0.42424242424242425, 8.258419113680198, 1.8717830390292727, 'UPHENO:0076735', 'abnormal alimentary part of gastrointestinal system morphology'),
(268408, 'HP:0100808', 'Gastric diverticulum', 'MP:0000489', 'abnormal large intestine morphology', 0.42424242424242425, 8.258419113680198, 1.8717830390292727, 'UPHENO:0076735', 'abnormal alimentary part of gastrointestinal system morphology'),
(268409, 'HP:0100808', 'Gastric diverticulum', 'MP:0010792', 'abnormal stomach mucosa morphology', 0.4444444444444444, 10.592196926445304, 2.1697103674039386, 'UPHENO:0081609', 'abnormal stomach morphology'),
(268410, 'HP:0100808', 'Gastric diverticulum', 'MP:0010783', 'abnormal stomach wall morphology', 0.47058823529411764, 10.592196926445304, 2.2326135490728514, 'UPHENO:0081609', 'abnormal stomach morphology'),
(268411, 'HP:0100808', 'Gastric diverticulum', 'MP:0010158', 'abnormal intestine development', 0.42424242424242425, 8.258419113680198, 1.8717830390292727, 'UPHENO:0076735', 'abnormal alimentary part of gastrointestinal system morphology'),
(268412, 'HP:0100808', 'Gastric diverticulum', 'MP:0010778', 'abnormal stomach fundus morphology', 0.47058823529411764, 10.592196926445304, 2.2326135490728514, 'UPHENO:0081609', 'abnormal stomach morphology'),
(268413, 'HP:0100808', 'Gastric diverticulum', 'MP:0010794', 'abnormal stomach submucosa morphology', 0.4444444444444444, 10.592196926445304, 2.1697103674039386, 'UPHENO:0081609', 'abnormal stomach morphology'),
(268414, 'HP:0100808', 'Gastric diverticulum', 'MP:0000496', 'abnormal small intestine morphology', 0.4117647058823529, 8.258419113680198, 1.8440513868647284, 'UPHENO:0076735', 'abnormal alimentary part of gastrointestinal system morphology'),
(268415, 'HP:0100808', 'Gastric diverticulum', 'MP:0003282', 'gastric ulcer', 0.41025641025641024, 10.592196926445304, 2.0845902925449, 'UPHENO:0081609', 'abnormal stomach morphology'),
(268416, 'HP:0100808', 'Gastric diverticulum', 'MP:0003262', 'intestinal/bowel diverticulum', 0.4375, 8.258419113680198, 1.9008046617775027, 'UPHENO:0076735', 'abnormal alimentary part of gastrointestinal system morphology'),
(268417, 'HP:0100808', 'Gastric diverticulum', 'MP:0013948', 'intraembryonal intestine elongation', 0.4117647058823529, 8.258419113680198, 1.8440513868647284, 'UPHENO:0076735', 'abnormal alimentary part of gastrointestinal system morphology'),
(268418, 'HP:0100808', 'Gastric diverticulum', 'MP:0010807', 'abnormal stomach position or orientation', 0.41025641025641024, 10.592196926445304, 2.0845902925449, 'UPHENO:0081609', 'abnormal stomach morphology'),
(268419, 'HP:0100808', 'Gastric diverticulum', 'MP:0010784', 'abnormal forestomach morphology', 0.47058823529411764, 10.592196926445304, 2.2326135490728514, 'UPHENO:0081609', 'abnormal stomach morphology'),
(268420, 'HP:0100808', 'Gastric diverticulum', 'MP:0000474', 'abnormal foregut morphology', 0.41935483870967744, 7.7347288895598965, 1.8009986079796043, 'UPHENO:0087359', 'abnormal foregut morphology'),
(268421, 'HP:0100808', 'Gastric diverticulum', 'MP:0011974', 'intestinal stenosis', 0.4117647058823529, 8.258419113680198, 1.8440513868647284, 'UPHENO:0076735', 'abnormal alimentary part of gastrointestinal system morphology'),
(268422, 'HP:0100808', 'Gastric diverticulum', 'MP:0010789', 'abnormal stomach mesentery morphology', 0.47058823529411764, 10.592196926445304, 2.2326135490728514, 'UPHENO:0081609', 'abnormal stomach morphology'),
(268423, 'HP:0100808', 'Gastric diverticulum', 'MP:0013575', 'abnormal forestomach-glandular stomach junction morphology', 0.47058823529411764, 10.592196926445304, 2.2326135490728514, 'UPHENO:0081609', 'abnormal stomach morphology'),
(268424, 'HP:0100808', 'Gastric diverticulum', 'MP:0010791', 'abnormal pyloric canal morphology', 0.43243243243243246, 10.592196926445304, 2.1401891228828536, 'UPHENO:0081609', 'abnormal stomach morphology'),
(268425, 'HP:0100808', 'Gastric diverticulum', 'MP:0010787', 'gastric cyst', 0.42105263157894735, 10.592196926445304, 2.111840995454495, 'UPHENO:0081609', 'abnormal stomach morphology'),
(268426, 'HP:0100808', 'Gastric diverticulum', 'MP:0003299', 'gastric polyps', 0.47058823529411764, 10.592196926445304, 2.2326135490728514, 'UPHENO:0081609', 'abnormal stomach morphology'),
(268427, 'HP:0100808', 'Gastric diverticulum', 'MP:0003323', 'gastrocolic fistula', 0.41025641025641024, 10.592196926445304, 2.0845902925449, 'UPHENO:0081609', 'abnormal stomach morphology'),
(268428, 'HP:0100808', 'Gastric diverticulum', 'MP:0014231', 'intestinal mucus accumulation', 0.4375, 8.258419113680198, 1.9008046617775027, 'UPHENO:0076735', 'abnormal alimentary part of gastrointestinal system morphology'),
(268429, 'HP:0100808', 'Gastric diverticulum', 'MP:0000477', 'abnormal intestine morphology', 0.45161290322580644, 8.258419113680198, 1.9312194675863759, 'UPHENO:0076735', 'abnormal alimentary part of gastrointestinal system morphology'),
(268430, 'HP:0100808', 'Gastric diverticulum', 'MP:0010798', 'abnormal stomach cardiac region morphology', 0.47058823529411764, 10.592196926445304, 2.2326135490728514, 'UPHENO:0081609', 'abnormal stomach morphology'),
(268431, 'HP:0100808', 'Gastric diverticulum', 'MP:0014159', 'stomach fibrosis', 0.41025641025641024, 10.592196926445304, 2.0845902925449, 'UPHENO:0081609', 'abnormal stomach morphology'),
(268432, 'HP:0100808', 'Gastric diverticulum', 'MP:0008011', 'intestine polyps', 0.42424242424242425, 8.258419113680198, 1.8717830390292727, 'UPHENO:0076735', 'abnormal alimentary part of gastrointestinal system morphology'),
(268433, 'HP:0100808', 'Gastric diverticulum', 'MP:0003307', 'pyloric stenosis', 0.42105263157894735, 10.592196926445304, 2.111840995454495, 'UPHENO:0081609', 'abnormal stomach morphology'),
(268434, 'HP:0100808', 'Gastric diverticulum', 'MP:0005214', 'regional gastric metaplasia', 0.47058823529411764, 10.592196926445304, 2.2326135490728514, 'UPHENO:0081609', 'abnormal stomach morphology'),
(268435, 'HP:0100808', 'Gastric diverticulum', 'MP:0000470', 'abnormal stomach morphology', 0.5, 10.592196926445304, 2.301325371003121, 'UPHENO:0081609', 'abnormal stomach morphology'),
(268436, 'HP:0100808', 'Gastric diverticulum', 'MP:0013578', 'abnormal stomach glandular region morphology', 0.47058823529411764, 10.592196926445304, 2.2326135490728514, 'UPHENO:0081609', 'abnormal stomach morphology'),
(268437, 'HP:0100808', 'Gastric diverticulum', 'MP:0010790', 'abnormal stomach pyloric antrum morphology', 0.43243243243243246, 10.592196926445304, 2.1401891228828536, 'UPHENO:0081609', 'abnormal stomach morphology'),
(268438, 'HP:0100808', 'Gastric diverticulum', 'MP:0000462', 'abnormal digestive system morphology', 0.41379310344827586, 5.838135946814261, 1.5542780934521376, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(268439, 'HP:0100808', 'Gastric diverticulum', 'MP:0003275', 'gastric microaneurysm', 0.43243243243243246, 10.592196926445304, 2.1401891228828536, 'UPHENO:0081609', 'abnormal stomach morphology'),
(268440, 'HP:0100808', 'Gastric diverticulum', 'MP:0005213', 'gastric metaplasia', 0.48484848484848486, 10.592196926445304, 2.266188569162722, 'UPHENO:0081609', 'abnormal stomach morphology'),
(268441, 'HP:0100808', 'Gastric diverticulum', 'MP:0005494', 'esophagogastric junction metaplasia', 0.4444444444444444, 10.592196926445304, 2.1697103674039386, 'UPHENO:0081609', 'abnormal stomach morphology'),
(268442, 'HP:0100808', 'Gastric diverticulum', 'MP:0010785', 'abnormal stomach pyloric region morphology', 0.45714285714285713, 10.592196926445304, 2.2004879382480143, 'UPHENO:0081609', 'abnormal stomach morphology'),
(268443, 'HP:0100808', 'Gastric diverticulum', 'MP:0010793', 'abnormal stomach serosa morphology', 0.4444444444444444, 10.592196926445304, 2.1697103674039386, 'UPHENO:0081609', 'abnormal stomach morphology'),
(268444, 'HP:0025429', 'Abnormal cry', 'MP:0001156', 'abnormal spermatogenesis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268445, 'HP:0025429', 'Abnormal cry', 'MP:0002114', 'abnormal axial skeleton morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268446, 'HP:0025429', 'Abnormal cry', 'MP:0031274', 'increased susceptibility to induced aneurysm formation', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268447, 'HP:0025429', 'Abnormal cry', 'MP:0005029', 'abnormal amnion morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268448, 'HP:0025429', 'Abnormal cry', 'MP:0000003', 'abnormal adipose tissue morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268449, 'HP:0025429', 'Abnormal cry', 'MP:0001986', 'abnormal taste sensitivity', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268450, 'HP:0025429', 'Abnormal cry', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268451, 'HP:0025429', 'Abnormal cry', 'MP:0000752', 'dystrophic muscle', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268452, 'HP:0025429', 'Abnormal cry', 'MP:0010425', 'abnormal heart and great vessel attachment', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268453, 'HP:0025429', 'Abnormal cry', 'MP:0004179', 'transmission ratio distortion', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268454, 'HP:0025429', 'Abnormal cry', 'MP:0002160', 'abnormal reproductive system morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268455, 'HP:0025429', 'Abnormal cry', 'MP:0020452', 'abnormal axon radial sorting', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268456, 'HP:0025429', 'Abnormal cry', 'MP:0002109', 'abnormal limb morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268457, 'HP:0025429', 'Abnormal cry', 'MP:0011203', 'abnormal parietal yolk sac morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268458, 'HP:0025429', 'Abnormal cry', 'MP:0005508', 'abnormal skeleton morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268459, 'HP:0025429', 'Abnormal cry', 'MP:0005422', 'osteosclerosis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268460, 'HP:0025429', 'Abnormal cry', 'MP:0014137', 'abnormal preimplantation embryo morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268461, 'HP:0025429', 'Abnormal cry', 'MP:0003115', 'abnormal respiratory system development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268462, 'HP:0025429', 'Abnormal cry', 'MP:0001890', 'anencephaly', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268463, 'HP:0025429', 'Abnormal cry', 'MP:0013124', 'mouth swellings', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268464, 'HP:0025429', 'Abnormal cry', 'MP:0005500', 'abnormal gustatory system morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268465, 'HP:0025429', 'Abnormal cry', 'MP:0003633', 'abnormal nervous system physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268466, 'HP:0025429', 'Abnormal cry', 'MP:0000266', 'abnormal heart morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268467, 'HP:0025429', 'Abnormal cry', 'MP:0001985', 'abnormal gustatory system physiology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268468, 'HP:0025429', 'Abnormal cry', 'MP:0002108', 'abnormal muscle morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268469, 'HP:0025429', 'Abnormal cry', 'MP:0003279', 'aneurysm', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268470, 'HP:0025429', 'Abnormal cry', 'MP:0031277', 'pectus carinatum', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268471, 'HP:0025429', 'Abnormal cry', 'MP:0000731', 'increased collagen deposition in the muscles', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268472, 'HP:0025429', 'Abnormal cry', 'MP:0014067', 'Hirano bodies', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268473, 'HP:0025429', 'Abnormal cry', 'MP:0001726', 'abnormal allantois morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268474, 'HP:0025429', 'Abnormal cry', 'MP:0000759', 'abnormal skeletal muscle morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268475, 'HP:0025429', 'Abnormal cry', 'MP:0031310', 'abnormal cyst', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268476, 'HP:0025429', 'Abnormal cry', 'MP:0005459', 'decreased percent body fat/body weight', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268477, 'HP:0025429', 'Abnormal cry', 'MP:0010352', 'gastrointestinal tract polyps', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268478, 'HP:0025429', 'Abnormal cry', 'MP:0003300', 'gastrointestinal ulcer', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268479, 'HP:0025429', 'Abnormal cry', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268480, 'HP:0025429', 'Abnormal cry', 'MP:0004134', 'abnormal chest morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268481, 'HP:0025429', 'Abnormal cry', 'MP:0000767', 'abnormal smooth muscle morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268482, 'HP:0025429', 'Abnormal cry', 'MP:0002132', 'abnormal respiratory system morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268483, 'HP:0025429', 'Abnormal cry', 'MP:0014134', 'abnormal embryo morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268484, 'HP:0025429', 'Abnormal cry', 'MP:0013133', 'pale limbs', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268485, 'HP:0025429', 'Abnormal cry', 'MP:0013083', 'tail wound', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268486, 'HP:0025429', 'Abnormal cry', 'MP:0031273', 'decreased susceptibility to induced aneurysm formation', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268487, 'HP:0025429', 'Abnormal cry', 'MP:0010122', 'abnormal bone mineral content', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268488, 'HP:0025429', 'Abnormal cry', 'MP:0020515', 'abnormal visceral yolk sac endoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268489, 'HP:0025429', 'Abnormal cry', 'MP:0013126', 'teat swellings', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268490, 'HP:0025429', 'Abnormal cry', 'MP:0002164', 'abnormal gland physiology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268491, 'HP:0025429', 'Abnormal cry', 'MP:0000556', 'abnormal hindlimb morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268492, 'HP:0025429', 'Abnormal cry', 'MP:0003384', 'abnormal ventral body wall morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268493, 'HP:0025429', 'Abnormal cry', 'MP:0013558', 'abnormal exocrine gland morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268494, 'HP:0025429', 'Abnormal cry', 'MP:0031099', 'abnormal sputum morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268495, 'HP:0025429', 'Abnormal cry', 'MP:0013258', 'abnormal extracellular matrix morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268496, 'HP:0025429', 'Abnormal cry', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268497, 'HP:0025429', 'Abnormal cry', 'MP:0031377', 'ambiguous external genitalia', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268498, 'HP:0025429', 'Abnormal cry', 'MP:0014063', 'Lafora bodies', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268499, 'HP:0025429', 'Abnormal cry', 'MP:0006281', 'abnormal tail development', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268500, 'HP:0025429', 'Abnormal cry', 'MP:0002211', 'abnormal primary sex determination', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268501, 'HP:0025429', 'Abnormal cry', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268502, 'HP:0025429', 'Abnormal cry', 'MP:0001919', 'abnormal reproductive system physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268503, 'HP:0025429', 'Abnormal cry', 'MP:0009250', 'abnormal appendicular skeleton morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268504, 'HP:0025429', 'Abnormal cry', 'MP:0000358', 'abnormal cell morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268505, 'HP:0025429', 'Abnormal cry', 'MP:0002060', 'abnormal skin morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268506, 'HP:0025429', 'Abnormal cry', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268507, 'HP:0025429', 'Abnormal cry', 'MP:0000736', 'delayed muscle development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268508, 'HP:0025429', 'Abnormal cry', 'MP:0005334', 'abnormal fat pad morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268509, 'HP:0025429', 'Abnormal cry', 'MP:0020973', 'abnormal gland development', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268510, 'HP:0025429', 'Abnormal cry', 'MP:0010678', 'abnormal skin adnexa morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268511, 'HP:0025429', 'Abnormal cry', 'MP:0014062', 'nervous system inclusion bodies', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268512, 'HP:0025429', 'Abnormal cry', 'MP:0014064', 'argyrophilic inclusion bodies', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268513, 'HP:0025429', 'Abnormal cry', 'MP:0020981', 'abnormal immune system development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268514, 'HP:0025429', 'Abnormal cry', 'MP:0031348', 'bone fibrous dysplasia', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268515, 'HP:0025429', 'Abnormal cry', 'MP:0002212', 'abnormal secondary sex determination', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268516, 'HP:0025429', 'Abnormal cry', 'MP:0013332', 'peliosis', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268517, 'HP:0025429', 'Abnormal cry', 'MP:0010126', 'abnormal distal visceral endoderm morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268518, 'HP:0025429', 'Abnormal cry', 'MP:0013119', 'abdomen swellings', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268519, 'HP:0025429', 'Abnormal cry', 'MP:0020516', 'abnormal visceral yolk sac mesenchyme morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268520, 'HP:0025429', 'Abnormal cry', 'MP:0002970', 'abnormal white adipose tissue morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268521, 'HP:0025429', 'Abnormal cry', 'MP:0002399', 'abnormal pluripotent precursor cell morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268522, 'HP:0025429', 'Abnormal cry', 'MP:0005458', 'increased percent body fat/body weight', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268523, 'HP:0025429', 'Abnormal cry', 'MP:0005504', 'abnormal ligament morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268524, 'HP:0025429', 'Abnormal cry', 'MP:0005621', 'abnormal cell physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268525, 'HP:0025429', 'Abnormal cry', 'MP:0003795', 'abnormal bone structure', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268526, 'HP:0025429', 'Abnormal cry', 'MP:0006279', 'abnormal limb development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268527, 'HP:0025429', 'Abnormal cry', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268528, 'HP:0025429', 'Abnormal cry', 'MP:0011174', 'lipodystrophy', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268529, 'HP:0025429', 'Abnormal cry', 'MP:0002837', 'dystrophic cardiac calcinosis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268530, 'HP:0025429', 'Abnormal cry', 'MP:0003301', 'peptic ulcer', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268531, 'HP:0025429', 'Abnormal cry', 'MP:0013118', 'swellings', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268532, 'HP:0025429', 'Abnormal cry', 'MP:0000462', 'abnormal digestive system morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268533, 'HP:0025429', 'Abnormal cry', 'MP:0001944', 'abnormal pancreas morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268534, 'HP:0025429', 'Abnormal cry', 'MP:0003385', 'abnormal body wall morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268535, 'HP:0025429', 'Abnormal cry', 'MP:0002184', 'abnormal innervation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268536, 'HP:0025429', 'Abnormal cry', 'MP:0001175', 'abnormal lung morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268537, 'HP:0025429', 'Abnormal cry', 'MP:0000550', 'abnormal forelimb morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268538, 'HP:0025429', 'Abnormal cry', 'MP:0010233', 'hairless tail', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268539, 'HP:0025429', 'Abnormal cry', 'MP:0000733', 'abnormal muscle development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268540, 'HP:0025429', 'Abnormal cry', 'MP:0005457', 'abnormal percent body fat/body weight', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268541, 'HP:0025429', 'Abnormal cry', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268542, 'HP:0025429', 'Abnormal cry', 'MP:0020370', 'abnormal glymphatic system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268543, 'HP:0025429', 'Abnormal cry', 'MP:0012514', 'pectus excavatum', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268544, 'HP:0025429', 'Abnormal cry', 'MP:0013304', 'osteophytes', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268545, 'HP:0025429', 'Abnormal cry', 'MP:0002113', 'abnormal skeleton development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268546, 'HP:0025429', 'Abnormal cry', 'MP:0000428', 'abnormal craniofacial morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268547, 'HP:0025429', 'Abnormal cry', 'MP:0002836', 'abnormal chorion morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268548, 'HP:0025429', 'Abnormal cry', 'MP:0031100', 'hemoptysis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268549, 'HP:0025429', 'Abnormal cry', 'MP:0013122', 'tail swellings', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268550, 'HP:0025429', 'Abnormal cry', 'MP:0009877', 'exostosis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268551, 'HP:0025429', 'Abnormal cry', 'MP:0004558', 'delayed allantois development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268552, 'HP:0025429', 'Abnormal cry', 'MP:0002932', 'abnormal joint morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268553, 'HP:0025429', 'Abnormal cry', 'MP:0003942', 'abnormal urinary system development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268554, 'HP:0025429', 'Abnormal cry', 'MP:0002925', 'abnormal cardiovascular development', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268555, 'HP:0025429', 'Abnormal cry', 'MP:0011199', 'abnormal amniotic cavity morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268556, 'HP:0025429', 'Abnormal cry', 'MP:0001718', 'abnormal visceral yolk sac morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268557, 'HP:0025429', 'Abnormal cry', 'MP:0002163', 'abnormal gland morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268558, 'HP:0025429', 'Abnormal cry', 'MP:0013120', 'urogenital swellings', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268559, 'HP:0025429', 'Abnormal cry', 'MP:0001533', 'abnormal skeleton physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268560, 'HP:0025429', 'Abnormal cry', 'MP:0012531', 'delayed limb development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268561, 'HP:0025429', 'Abnormal cry', 'MP:0031092', 'dysgeusia', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268562, 'HP:0025429', 'Abnormal cry', 'MP:0010435', 'abnormal heart atrium and ventricle connection', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268563, 'HP:0025429', 'Abnormal cry', 'MP:0030222', 'hyperostosis', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268564, 'HP:0025429', 'Abnormal cry', 'MP:0013125', 'thorax swellings', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268565, 'HP:0025429', 'Abnormal cry', 'MP:0010874', 'abnormal bone volume', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268566, 'HP:0025429', 'Abnormal cry', 'MP:0003890', 'abnormal embryonic-extraembryonic boundary morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268567, 'HP:0025429', 'Abnormal cry', 'MP:0011488', 'abnormal ureterovesical junction morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268568, 'HP:0025429', 'Abnormal cry', 'MP:0002111', 'abnormal tail morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268569, 'HP:0025429', 'Abnormal cry', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268570, 'HP:0025429', 'Abnormal cry', 'MP:0011167', 'abnormal adipose tissue development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268571, 'HP:0025429', 'Abnormal cry', 'MP:0010736', 'abnormal extraembryonic ectoderm morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268572, 'HP:0025429', 'Abnormal cry', 'MP:0013113', 'greasy tail', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268573, 'HP:0025429', 'Abnormal cry', 'MP:0013121', 'testicular swellings', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268574, 'HP:0025429', 'Abnormal cry', 'MP:0000685', 'abnormal immune system morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268575, 'HP:0025429', 'Abnormal cry', 'MP:0012058', 'abnormal morula morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268576, 'HP:0025429', 'Abnormal cry', 'MP:0000566', 'synostosis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268577, 'HP:0025429', 'Abnormal cry', 'MP:0002971', 'abnormal brown adipose tissue morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268578, 'HP:0025429', 'Abnormal cry', 'MP:0002133', 'abnormal respiratory system physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268579, 'HP:0025429', 'Abnormal cry', 'MP:0013123', 'head/neck swellings', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268580, 'HP:0025429', 'Abnormal cry', 'MP:0008923', 'thoracoschisis', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268581, 'HP:0025429', 'Abnormal cry', 'MP:0003632', 'abnormal nervous system morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268582, 'HP:0025429', 'Abnormal cry', 'MP:0008493', 'alpha-synuclein inclusion body', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268583, 'HP:0025429', 'Abnormal cry', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268584, 'HP:0025429', 'Abnormal cry', 'MP:0001790', 'abnormal immune system physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268585, 'HP:0025429', 'Abnormal cry', 'MP:0001725', 'abnormal umbilical cord morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268586, 'HP:0025429', 'Abnormal cry', 'MP:0000427', 'abnormal hair cycle', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268587, 'HP:0025429', 'Abnormal cry', 'MP:0012260', 'encephalomeningocele', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268588, 'HP:0025429', 'Abnormal cry', 'MP:0010820', 'abnormal pleura morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268589, 'HP:0025429', 'Abnormal cry', 'MP:0010942', 'abnormal respiratory epithelium morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268590, 'HP:0025429', 'Abnormal cry', 'MP:0014136', 'abnormal extraembryonic endoderm morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268591, 'HP:0025429', 'Abnormal cry', 'MP:0001929', 'abnormal gametogenesis', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268592, 'HP:0025429', 'Abnormal cry', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268593, 'HP:0025429', 'Abnormal cry', 'MP:0003936', 'abnormal reproductive system development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268594, 'HP:0025429', 'Abnormal cry', 'MP:0030485', 'abnormal osteocyte lacunocanalicular system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268595, 'HP:0025429', 'Abnormal cry', 'MP:0030572', 'abnormal pilosebaceous unit morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268596, 'HP:0025429', 'Abnormal cry', 'MP:0011487', 'abnormal ureteropelvic junction morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268597, 'HP:0025429', 'Abnormal cry', 'MP:0010478', 'intracranial aneurysm', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268598, 'HP:0025429', 'Abnormal cry', 'MP:0014065', 'Lewy bodies', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268599, 'HP:0025429', 'Abnormal cry', 'MP:0004957', 'abnormal blastocyst morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268600, 'HP:0025429', 'Abnormal cry', 'MP:0001984', 'abnormal olfaction', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268601, 'HP:0025429', 'Abnormal cry', 'MP:0012685', 'abnormal primitive streak elongation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268602, 'HP:0025429', 'Abnormal cry', 'MP:0013177', 'abnormal tail tip morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268603, 'HP:0025429', 'Abnormal cry', 'MP:0005652', 'sex reversal', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268604, 'HP:0025429', 'Abnormal cry', 'MP:0001722', 'pale yolk sac', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268605, 'HP:0025429', 'Abnormal cry', 'MP:0014066', 'Rosenthal fibers', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268606, 'HP:0025429', 'Abnormal cry', 'MP:0001983', 'abnormal olfactory system physiology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268607, 'HP:0025429', 'Abnormal cry', 'MP:0011200', 'abnormal extraembryonic coelom morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268608, 'HP:0025429', 'Abnormal cry', 'MP:0005499', 'abnormal olfactory system morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268609, 'HP:0025429', 'Abnormal cry', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268610, 'HP:0025429', 'Abnormal cry', 'MP:0002396', 'abnormal hematopoietic system morphology/development', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268611, 'HP:0025429', 'Abnormal cry', 'MP:0005666', 'abnormal adipose tissue physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268612, 'HP:0025429', 'Abnormal cry', 'MP:0000467', 'abnormal esophagus morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268613, 'HP:0025429', 'Abnormal cry', 'MP:0003861', 'abnormal nervous system development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268614, 'HP:0025429', 'Abnormal cry', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268615, 'HP:0025429', 'Abnormal cry', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268616, 'HP:0025429', 'Abnormal cry', 'MP:0013283', 'failure of ventral body wall closure', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268617, 'HP:0025429', 'Abnormal cry', 'MP:0002210', 'abnormal sex determination', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268618, 'HP:0025429', 'Abnormal cry', 'MP:0012684', 'abnormal pleural cavity morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268619, 'HP:0025429', 'Abnormal cry', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268620, 'HP:0025429', 'Abnormal cry', 'MP:0003705', 'abnormal hypodermis morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268621, 'HP:0025429', 'Abnormal cry', 'MP:0004996', 'abnormal CNS synapse formation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268622, 'HP:0025429', 'Abnormal cry', 'MP:0005360', 'urolithiasis', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268623, 'HP:0025429', 'Abnormal cry', 'MP:0002653', 'abnormal ependyma morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268624, 'HP:0025429', 'Abnormal cry', 'MP:0008533', 'abnormal anterior visceral endoderm morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268625, 'HP:0025429', 'Abnormal cry', 'MP:0012070', 'abnormal susceptibility to osteoporosis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268626, 'HP:0025429', 'Abnormal cry', 'MP:0012500', 'abnormal angioblastic cord morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268627, 'HP:0025429', 'Abnormal cry', 'MP:0002085', 'abnormal embryonic tissue morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268628, 'HP:0025429', 'Abnormal cry', 'MP:0003935', 'abnormal craniofacial development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268629, 'HP:0025429', 'Abnormal cry', 'MP:0002106', 'abnormal muscle physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268630, 'HP:0025429', 'Abnormal cry', 'MP:0006280', 'abnormal digit development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268631, 'HP:0025429', 'Abnormal cry', 'MP:0003119', 'abnormal digestive system development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268632, 'HP:0025429', 'Abnormal cry', 'MP:0001663', 'abnormal digestive system physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268633, 'HP:0025429', 'Abnormal cry', 'MP:0020982', 'abnormal skin adnexa development', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268634, 'HP:0025429', 'Abnormal cry', 'MP:0010680', 'abnormal skin adnexa physiology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268635, 'HP:0025429', 'Abnormal cry', 'MP:0000572', 'abnormal autopod morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268636, 'HP:0025429', 'Abnormal cry', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268637, 'HP:0025429', 'Abnormal cry', 'MP:0004557', 'dilated allantois', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(268638, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0012330', 'decreased circulating fibrinogen level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268639, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0002965', 'increased circulating serum albumin level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268640, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0012327', 'abnormal circulating factor VIII level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268641, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0012661', 'decreased circulating ceruloplasmin level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268642, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0021034', 'abnormal circulating cartilage oligomeric matrix protein level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268643, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0031341', 'decreased circulating lipocalin 2 level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268644, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0012664', 'decreased circulating haptoglobin level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268645, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0031077', 'increased circulating troponin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268646, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0020247', 'increased circulating arginase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268647, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0005419', 'decreased circulating serum albumin level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268648, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0011886', 'increased circulating lipase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268649, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0012333', 'increased circulating fibronectin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268650, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0012615', 'decreased circulating factor IX level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268651, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0031165', 'increased circulating von Willebrand factor level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268652, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0011888', 'abnormal circulating total protein level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268653, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0011008', 'abnormal circulating glutamate dehydrogenase level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268654, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0031081', 'abnormal circulating D-dimer level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268655, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0005632', 'decreased circulating aspartate transaminase level', 0.4375, 9.555485148088783, 2.0446331583657846, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268656, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0012329', 'increased circulating factor VIII level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268657, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0011893', 'increased circulating transferrin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268658, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0013255', 'abnormal circulating thrombin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268659, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0008459', 'abnormal circulating pancreatic peptide level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(268660, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0031164', 'decreased circulating von Willebrand factor level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268661, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0031076', 'decreased circulating troponin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268662, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0030744', 'abnormal circulating homocitrulline level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(268663, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0010330', 'abnormal circulating lipoprotein level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(268664, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0020986', 'abnormal circulating ceruloplasmin level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268665, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0031074', 'increased circulating type I collagen C-terminal telopeptide level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268666, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0031234', 'increased circulating serum amyloid protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268667, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0010333', 'abnormal circulating apolipoprotein E level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268668, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0012620', 'abnormal circulating factor XIII level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268669, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0010106', 'abnormal circulating pyruvate kinase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268670, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0008805', 'decreased circulating amylase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268671, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0011895', 'abnormal circulating unsaturated transferrin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268672, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0031073', 'decreased circulating type I collagen C-terminal telopeptide level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268673, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0021035', 'decreased circulating cartilage oligomeric matrix protein level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268674, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0020983', 'abnormal circulating factor XI level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268675, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0005416', 'abnormal circulating protein level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268676, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0012614', 'abnormal circulating factor IX level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268677, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0001560', 'abnormal circulating insulin level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(268678, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0010332', 'abnormal circulating apolipoprotein level', 0.4375, 9.555485148088783, 2.0446331583657846, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268679, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0031107', 'abnormal circulating myoglobin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268680, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0021036', 'increased circulating cartilage oligomeric matrix protein level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268681, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0020257', 'increased circulating factor XII level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268682, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0008820', 'abnormal blood uric acid level', 0.4634146341463415, 8.001050554100775, 1.9255658688590722, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(268683, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0020255', 'absent circulating factor XII protein', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268684, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0011885', 'abnormal circulating lipase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268685, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0012221', 'abnormal circulating prothrombin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268686, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0008806', 'increased circulating amylase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268687, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0012326', 'increased circulating antithrombin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268688, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0031075', 'abnormal circulating troponin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268689, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0011972', 'decreased circulating lactate dehydrogenase level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268690, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0012622', 'increased circulating factor XIII level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268691, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0031342', 'increased circulating lipocalin 2 level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268692, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0002941', 'increased circulating alanine transaminase level', 0.4375, 9.555485148088783, 2.0446331583657846, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268693, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0010213', 'abnormal circulating fibrinogen level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268694, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0000202', 'abnormal circulating alkaline phosphatase level', 0.4375, 9.555485148088783, 2.0446331583657846, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268695, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0002903', 'abnormal circulating parathyroid hormone level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(268696, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0012662', 'increased circulating ceruloplasmin level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268697, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0012328', 'decreased circulating factor VIII level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268698, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0030624', 'abnormal circulating cysteine level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(268699, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0005265', 'abnormal blood urea nitrogen level', 0.4634146341463415, 8.001050554100775, 1.9255658688590722, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(268700, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0012616', 'increased circulating factor IX level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268701, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0012619', 'increased circulating factor X level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268702, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0012332', 'decreased circulating fibronectin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268703, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0008804', 'abnormal circulating amylase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268704, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0020985', 'increased circulating factor XI level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268705, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0010210', 'abnormal circulating cytokine level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268706, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0031083', 'increased circulating D-dimer level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268707, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0005311', 'abnormal circulating amino acid level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(268708, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0011896', 'increased circulating unsaturated transferrin level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268709, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0011970', 'abnormal circulating lactate dehydrogenase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268710, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0001573', 'abnormal circulating alanine transaminase level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268711, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0013256', 'increased circulating thrombin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268712, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0031108', 'increased circulating myoglobin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268713, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0012331', 'increased circulating fibrinogen level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268714, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0011912', 'abnormal circulating fibronectin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268715, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0011971', 'increased circulating lactate dehydrogenase level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268716, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0031059', 'increased circulating C-reactive protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268717, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0012324', 'abnormal circulating antithrombin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268718, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0005521', 'abnormal circulating atrial natriuretic factor level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(268719, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0012666', 'increased circulating haptoglobin level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268720, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0031114', 'increased circulating gamma-glutamyl transferase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268721, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0006373', 'abnormal circulating angiotensinogen level', 0.4375, 9.555485148088783, 2.0446331583657846, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268722, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0020984', 'decreased circulating factor XI level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268723, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0005567', 'decreased circulating total protein level', 0.42857142857142855, 9.555485148088783, 2.023662007502606, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268724, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0031079', 'increased circulating troponin I level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268725, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0012222', 'decreased circulating prothrombin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268726, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0031082', 'decreased circulating D-dimer level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268727, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0002695', 'abnormal circulating glucagon level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(268728, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0001570', 'abnormal circulating enzyme level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268729, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0011890', 'increased circulating ferritin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268730, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0011894', 'decreased circulating transferrin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268731, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0001569', 'abnormal circulating bilirubin level', 0.4318181818181818, 8.001050554100775, 1.8587627882296205, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(268732, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0010214', 'abnormal circulating serum amyloid protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268733, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0013403', 'abnormal circulating lactate level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(268734, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0011892', 'abnormal circulating transferrin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268735, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0000199', 'abnormal circulating serum albumin level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268736, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0000203', 'abnormal circulating aspartate transaminase level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268737, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0011611', 'abnormal circulating ghrelin level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(268738, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0031072', 'abnormal circulating type I collagen C-terminal telopeptide level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268739, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0021039', 'decreased circulating orosomucoid 1 protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268740, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0011897', 'decreased circulating unsaturated transferrin level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268741, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0031340', 'abnormal circulating lipocalin 2 level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268742, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0011889', 'abnormal circulating ferritin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268743, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0013257', 'decreased circulating thrombin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268744, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0031065', 'increased circulating procalcitonin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268745, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0002942', 'decreased circulating alanine transaminase level', 0.4375, 9.555485148088783, 2.0446331583657846, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268746, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0012618', 'decreased circulating factor X level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268747, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0005308', 'abnormal circulating ammonia level', 0.4318181818181818, 8.001050554100775, 1.8587627882296205, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(268748, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0012621', 'decreased circulating factor XIII level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268749, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0020246', 'abnormal circulating arginase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268750, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0003349', 'abnormal circulating renin level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268751, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0012325', 'decreased circulating antithrombin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268752, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0031078', 'increased circulating troponin T level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268753, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0020256', 'abnormal circulating factor XII level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268754, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0030745', 'increased circulating homocitrulline level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(268755, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0010216', 'abnormal circulating retinol binding protein level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268756, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0020341', 'abnormal circulating hyaluronic acid level', 0.4318181818181818, 8.001050554100775, 1.8587627882296205, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(268757, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0030757', 'abnormal circulating histamine level', 0.4318181818181818, 8.001050554100775, 1.8587627882296205, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(268758, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0010215', 'abnormal circulating complement protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268759, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0010212', 'abnormal circulating C-reactive protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268760, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0021037', 'abnormal circulating orosomucoid 1 protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268761, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0012223', 'increased circulating prothrombin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268762, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0010089', 'abnormal circulating creatine kinase level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268763, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0010091', 'decreased circulating creatine kinase level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268764, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0011887', 'decreased circulating lipase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268765, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0031060', 'decreased circulating C-reactive protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268766, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0012617', 'abnormal circulating factor X level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268767, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0010090', 'increased circulating creatine kinase level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268768, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0020258', 'decreased circulating factor XII level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268769, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0031233', 'decreased circulating serum amyloid protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268770, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0020248', 'decreased circulating arginase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268771, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0004730', 'abnormal circulating gastrin level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(268772, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0021038', 'increased circulating orosomucoid 1 protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(268773, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0005667', 'abnormal circulating leptin level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(268774, 'HP:0033299', 'Reduced circulating complement factor H related protein 1 concentration', 'MP:0031064', 'abnormal circulating procalcitonin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
